| | Abasaglar | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Abidec / Dalivit | (9.6 Vitamin deficiencies) |
| | Acamprosate | (4.8 Substance dependence) |
| | Acetazolamide 250mg tablets | (2.8 Oedema) |
| | Acetazolamide immediate & modified release (oral) | (11.6 Treatment of glaucoma) |
| | Acetylcysteine 5% eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Aclidinium (Eklira Genuair) | (3.1 Airways disease, obstructive) |
| | Actimorph orodispersible tablets | (4.5 Pain) |
| | Adex gel | (13.1 Dry and scaling skin disorders) |
| | Alfentanil injection 500micrograms/mL, 5mg/mL | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Alfentanil injection | (16.6 End of life symptom control- Palliative Care) |
| | Alfentanil nasal / buccal / sublingual spray | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Alfuzosin modified-release | (7.1 Bladder and urinary disorders) |
| | Allpresan diabetic intensive foam cream (10% urea) | (13.1 Dry and scaling skin disorders) |
| | Almotriptan | (4.5 Pain) |
| | Alogliptin | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Altrajuce | (9.5 Nutrition) |
| | Altraplen Compact Daily | (9.5 Nutrition) |
| | Altraplen Compact | (9.5 Nutrition) |
| | Altraplen Protein | (9.5 Nutrition) |
| | Alverine citrate | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Amisulpride | (4.2 Mental health disorders) |
| | Amitriptyline | (4.2 Mental health disorders) |
| | Amitriptyline | (4.5 Pain) |
| | Amorolfine 5% nail solution (Loceryl) | (13.2 Infections of the skin) |
| | Amoxicillin (parenteral) | (5.2 Bacterial infection) |
| | Analogue Basal | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Antacids | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Antibiotics | (16.3 Respiratory symptoms- Palliative Care) |
| | Apraclonidine 1% eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | AproDerm colloidal oat cream (Paraffin-free) | (13.1 Dry and scaling skin disorders) |
| | Aproderm emollient cream | (13.1 Dry and scaling skin disorders) |
| | Aproderm gel | (13.1 Dry and scaling skin disorders) |
| | Arachis oil | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Artificial saliva spray (Glandosane, AS Saliva Orthana) | (12.3 Oropharynx) |
| | Asacol modified-release tablets | (1.1 Chronic bowel disorders) |
| | Atenolol | (6.9 Thyroid disorders) |
| | Axsain cream | (4.5 Pain) |
| | Aymes ActaGain 600 | (9.5 Nutrition) |
| | Aymes ActaGain Juce | (9.5 Nutrition) |
| | Aymes Complete | (9.5 Nutrition) |
| | Azithromycin (oral) | (5.2 Bacterial infection) |
| | Baclofen | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Beclometasone / Formoterol / Glycopyrronium (Trimbow pMDI) | (3.1 Airways disease, obstructive) |
| | Beclometasone dipropionate (Clipper) | (1.1 Chronic bowel disorders) |
| | Bempedoic Acid | (2.6 Hyperlipidaemia) |
| | Bendroflumethiazide 2.5mg tablets | (2.4 Blood pressure conditions) |
| | Bendroflumethiazide 2.5mg tablets | (2.8 Oedema) |
| | Benztropine | (4.3 Movement disorders) |
| | Benzylpenicillin sodium (parenteral) | (5.2 Bacterial infection) |
| | Betamethasone 0.1% eye drops | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Bezafibrate | (2.6 Hyperlipidaemia) |
| | Bijuve | (6.8 Sex hormone responsive conditions) |
| | Bimatoprost 0.03% / Timolol 0.5% eye drops (brands include Ganfort) | (11.6 Treatment of glaucoma) |
| | Bimatoprost 100microgram/mL and 300microgram/mL eye drops | (11.6 Treatment of glaucoma) |
| | Bisacodyl | (1.2 Constipation and bowel cleansing) |
| | Brimonidine 0.2% / Timolol 0.5% eye drops (brands include Combigan) | (11.6 Treatment of glaucoma) |
| | Brinzolamide 10mg / Timolol 5mg/mL eye drops (brands include Azarga) | (11.6 Treatment of glaucoma) |
| | Bromocriptine | (4.3 Movement disorders) |
| | Budesonide (inhaled & nebulised) | (3.1 Airways disease, obstructive) |
| | Budesonide nasal spray | (12.2 Nose) |
| | Bumetanide | (2.8 Oedema) |
| | Buprenorphine patches | (4.5 Pain) |
| | Buprenorphine transdermal patches | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Bupropion Hydrochloride | (4.8 Substance dependence) |
| | Calcichew (calcium carbonate) chewable tablet | (9.2 Fluid and electrolyte imbalances) |
| | Calcium 500 (calcium carbonate) tablet | (9.2 Fluid and electrolyte imbalances) |
| | Calcium acetate (Phosex) | (9.2 Fluid and electrolyte imbalances) |
| | Candesartan | (4.5 Pain) |
| | Carbamazepine | (4.5 Pain) |
| | Carbocisteine | (16.3 Respiratory symptoms- Palliative Care) |
| | Carbomer 980 gel | (11.8 Miscellaneous ophthalmic preparations) |
| | Carmellose sodium eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Carvedilol | (2.4 Blood pressure conditions) |
| | Cefalexin (oral) | (5.2 Bacterial infection) |
| | Cefixime (oral) | (5.2 Bacterial infection) |
| | Ceftriaxone (parenteral) | (5.2 Bacterial infection) |
| | Celecoxib | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Cerazette | (7.3 Contraception) |
| | Cerelle | (7.3 Contraception) |
| | Cetraben ointment | (13.1 Dry and scaling skin disorders) |
| | Chlorpromazine | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Chlorpromazine | (4.2 Mental health disorders) |
| | Chlorthalidone | (2.8 Oedema) |
| | Ciclesonide (inhaled) | (3.1 Airways disease, obstructive) |
| | Cilique | (7.3 Contraception) |
| | Cimetidine | (1.4 Disorders of gastric acid and ulceration) |
| | Ciprofloxacin 0.3% / Dexamethasone 0.1% | (12.1 Ear) |
| | Clindamycin (oral) | (5.2 Bacterial infection) |
| | Clobetasone butyrate 0.05% / Oxytetracycline 3% / Nystatin 100,000 units/g cream (Trimovate) | (13.3 Inflammatory skin conditions) |
| | Clomifene | (6.8 Sex hormone responsive conditions) |
| | Clonazepam tablets / injection for subcutaneous use | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Clonazepam | (4.5 Pain) |
| | Clonidine | (2.4 Blood pressure conditions) |
| | Clotrimazole 1% solution | (12.1 Ear) |
| | Co-amilofruse | (2.8 Oedema) |
| | Co-amoxiclav (oral) | (5.2 Bacterial infection) |
| | Co-danthramer strong | (1.2 Constipation and bowel cleansing) |
| | Co-danthramer | (1.2 Constipation and bowel cleansing) |
| | Co-magaldrox 195/220 suspension (Mucogel - low in sodium) | (1.4 Disorders of gastric acid and ulceration) |
| | Co-trimoxazole (oral) | (5.2 Bacterial infection) |
| | Codeine linctus | (3.4 Cough and congestion) |
| | Codeine phosphate | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Corticosteroids | (4.5 Pain) |
| | Creon | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Cyanocobalamin | (9.1 Blood and blood–forming organs) |
| | Daridorexant | (4.7 Sleep disorders) |
| | Demeclocycline hydrochloride (oral) | (5.2 Bacterial infection) |
| | Dermatonics Dry Skin Balm (10% urea) | (13.1 Dry and scaling skin disorders) |
| | Dermatonics Once Heel Balm (25% urea) | (13.1 Dry and scaling skin disorders) |
| | Dexamethasone (oral & parenteral) | (6.2 Corticosteroid responsive conditions) |
| | Dexamethasone 0.05% / Framycetin 0.5% / Gramicidin 0.005% drops (Sofradex) | (12.1 Ear) |
| | Dexamethasone | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Dexamethasone | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Dexamethasone | (16.3 Respiratory symptoms- Palliative Care) |
| | Dexamethasone | (4.4 Nausea and labyrinth disorders) |
| | Diamorphine injection | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Diamorphine injection | (16.6 End of life symptom control- Palliative Care) |
| | Diamorphine | (4.5 Pain) |
| | Diazepam | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Diclofenac 3% gel (Solaraze) | (13.5 Photodamage) |
| | Diclofenac | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Diclofenac | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Dihydrocodeine | (4.5 Pain) |
| | Diltiazem 2% ointment or cream (unlicensed) | (1.9 Rectal and anal disorders) |
| | Diltiazem modified-release | (2.4 Blood pressure conditions) |
| | Dipyridamole modified-release in combination with aspirin | (2.3 Blood clots) |
| | Dipyridamole | (2.3 Blood clots) |
| | Disulfiram | (4.8 Substance dependence) |
| | Domperidone tablets / suppositories | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Domperidone | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Domperidone | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Donepezil | (4.1 Dementia) |
| | Dorzolamide 2% / Timolol 0.5% eye drops | (11.6 Treatment of glaucoma) |
| | Dosulepin | (4.5 Pain) |
| | Doublebase Once gel | (13.1 Dry and scaling skin disorders) |
| | Doxazosin | (2.4 Blood pressure conditions) |
| | Dretine | (7.3 Contraception) |
| | Duloxetine | (4.5 Pain) |
| | Dutasteride | (6.8 Sex hormone responsive conditions) |
| | Dutasteride | (7.1 Bladder and urinary disorders) |
| | Edoxaban | (2.3 Blood clots) |
| | Eflornithine 11.5% cream | (13.8 Scalp and hair conditions) |
| | Emollin | (13.1 Dry and scaling skin disorders) |
| | Ensure Compact | (9.5 Nutrition) |
| | Erythromycin (oral) | (5.2 Bacterial infection) |
| | Escitalopram | (4.2 Mental health disorders) |
| | Esomeprazole granules | (1.4 Disorders of gastric acid and ulceration) |
| | Esomeprazole tablets/capsules | (1.4 Disorders of gastric acid and ulceration) |
| | Estradot patch | (6.8 Sex hormone responsive conditions) |
| | Estring Vaginal Ring | (7.6 Vaginal and vulval conditions) |
| | Ethinylestradiol / Norelgestromin patch (Evra) | (7.3 Contraception) |
| | Etodolac | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Etoricoxib | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Exenatide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Famciclovir (oral) | (5.6 Viral infection) |
| | Febuxostat | (10.2 Hyperuricaemia and gout) |
| | Felodipine modified-release | (2.4 Blood pressure conditions) |
| | Femodene ED | (7.3 Contraception) |
| | Fenofibrate (micronised or modified-release) | (2.6 Hyperlipidaemia) |
| | Fentanyl citrate injection for subcutaneous use | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Fentanyl injection | (16.6 End of life symptom control- Palliative Care) |
| | Fentanyl injection | (4.5 Pain) |
| | Fentanyl lozenges | (4.5 Pain) |
| | Fentanyl patches | (4.5 Pain) |
| | Fentanyl subcutaneous injection | (16.3 Respiratory symptoms- Palliative Care) |
| | Fentanyl sublingual tablets (Abstral) | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Fentanyl sublingual tablets | (4.5 Pain) |
| | Fentanyl transdermal patches | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Fentanyl | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Ferric maltol capsules (Feraccru) | (9.1 Blood and blood–forming organs) |
| | Ferrous fumarate / Folic acid tablet (Pregaday) | (9.1 Blood and blood–forming organs) |
| | Ferrous gluconate tablet | (9.1 Blood and blood–forming organs) |
| | Fexofenadine | (3.2 Allergic conditions) |
| | Flucloxacillin (parenteral) | (5.2 Bacterial infection) |
| | Fluconazole capsules/oral suspension | (16.5 Mouthcare- Palliative Care) |
| | Flumetasone pivalate 0.02% / Clioquinol 1% drops (Locorten-Vioform) | (12.1 Ear) |
| | Fluocinolone 0.00625% | (13.3 Inflammatory skin conditions) |
| | Fluocinolone acetonide 0.025% gel/ointment/cream (Synalar) | (13.3 Inflammatory skin conditions) |
| | Fluorometholone 0.1% eye drops | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Fluorouracil 0.5% and Salicylic acid 10% (Actikerall) | (13.5 Photodamage) |
| | Fluticasone (inhaled & nebulised) | (3.1 Airways disease, obstructive) |
| | Fluticasone furoate spray (Avamys) | (12.2 Nose) |
| | Fluticasone nasal drops | (12.2 Nose) |
| | Fluvoxamine | (4.2 Mental health disorders) |
| | Formoterol / Aclidinium (Duaklir Genuair) | (3.1 Airways disease, obstructive) |
| | Formoterol / Glycopyrronium (Bevespi Aerosphere) | (3.1 Airways disease, obstructive) |
| | Fortisip Compact Fibre (4.5g) | (9.5 Nutrition) |
| | Fortisip Compact | (9.5 Nutrition) |
| | Fortisip | (9.5 Nutrition) |
| | Furosemide | (16.3 Respiratory symptoms- Palliative Care) |
| | Galantamine - includes prolonged-release capsules | (4.1 Dementia) |
| | Gelclair gel | (12.3 Oropharynx) |
| | Gelclair gel | (16.5 Mouthcare- Palliative Care) |
| | Gentamicin (parenteral) | (5.2 Bacterial infection) |
| | Gentamicin 0.3% eye drops | (11.3 Anti–infective eye preparations) |
| | Glimepiride | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Glucagon | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Glucose (parenteral) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Glycopyrronium (Seebri Breezhaler) | (3.1 Airways disease, obstructive) |
| | Glycopyrronium bromide | (16.5 Mouthcare- Palliative Care) |
| | Glycopyrronium bromide | (16.6 End of life symptom control- Palliative Care) |
| | Griseofulvin (oral) | (5.3 Fungal infection) |
| | Haloperidol tablets / liquid / capsules / subcutaneous injection | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Haloperidol | (16.6 End of life symptom control- Palliative Care) |
| | Haloperidol | (4.4 Nausea and labyrinth disorders) |
| | Humalog (KwikPen 200 units/mL) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Hyaluronidase | (10.5 Soft tissue and joint disorders) |
| | Hydralazine (oral) | (2.4 Blood pressure conditions) |
| | Hydrocortisone 1% / Gentamicin 0.3% drops (Gentisone HC) | (12.1 Ear) |
| | Hydromorphone injection | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Hydromorphone | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Hydromorphone | (4.5 Pain) |
| | Hydroxyzine | (3.2 Allergic conditions) |
| | Hyoscine butylbromide | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Hyoscine hydrobromide transdermal patch | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Hyoscine hydrobromide | (16.6 End of life symptom control- Palliative Care) |
| | Ibandronic acid 150mg tablet | (6.4 Disorders of bone metabolism) |
| | Icosapent ethyl | (2.6 Hyperlipidaemia) |
| | Inclisiran | (2.6 Hyperlipidaemia) |
| | Indacaterol (Onbrez Breezhaler) | (3.1 Airways disease, obstructive) |
| | Indacaterol / Glycopyrronium (UltiBro Breezhaler) | (3.1 Airways disease, obstructive) |
| | Indapamide 1.5mg modified-release tablets | (2.8 Oedema) |
| | Indometacin | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Ipratropium 0.03% spray (Rinatec) | (12.2 Nose) |
| | Irbesartan | (2.4 Blood pressure conditions) |
| | Itraconazole (oral) | (5.3 Fungal infection) |
| | Itraconazole capsules/oral liquid | (16.5 Mouthcare- Palliative Care) |
| | Ivermectin (oral) | (13.2 Infections of the skin) |
| | Ivermectin cream | (13.7 Rosacea and acne) |
| | Jaydess (Levonorgestrel intrauterine device) | (7.3 Contraception) |
| | Ketoconazole 2% cream (Nizoral) | (13.2 Infections of the skin) |
| | Ketotifen eye drops | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Labetalol (oral) | (2.4 Blood pressure conditions) |
| | Lamotrigine | (4.5 Pain) |
| | Lansoprazole fastabs | (1.4 Disorders of gastric acid and ulceration) |
| | Lantus | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Latanoprost 50micrograms / Timolol 5mg/mL (brands include Xalacom) | (11.6 Treatment of glaucoma) |
| | Lercanidipine | (2.4 Blood pressure conditions) |
| | Levemir | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Levofloxacin (oral) | (5.2 Bacterial infection) |
| | Levofloxacin 0.5% eye drops | (11.3 Anti–infective eye preparations) |
| | Levomepromazine | (4.4 Nausea and labyrinth disorders) |
| | Levomepromazine 6mg tablets (unlicensed)/25mg subcutaneous injection | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Levomepromazine subcutaneous injection | (16.6 End of life symptom control- Palliative Care) |
| | Levomepromazine | (16.6 End of life symptom control- Palliative Care) |
| | Lidocaine patch | (4.5 Pain) |
| | Linagliptin | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Liraglutide (Victoza) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Lixisenatide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Lizinna | (7.3 Contraception) |
| | Lofexidine | (4.8 Substance dependence) |
| | Loperamide tablets | (1.3 Diarrhoea) |
| | Lorazepam | (4.2 Mental health disorders) |
| | Lorazepam | (4.8 Substance dependence) |
| | Macrogols | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Magnesium oxide capsules | (9.2 Fluid and electrolyte imbalances) |
| | Malathion 0.5% liquid | (13.2 Infections of the skin) |
| | Mannitol (Osmohale) capsules | (3.6 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Marvelon | (7.3 Contraception) |
| | Mefenamic acid | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Meloxicam | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Memantine | (4.1 Dementia) |
| | Meningococcal Group B vaccine (Bexsero) | (14.4 Vaccination) |
| | Meningococcal Groups A, C, W135 and Y Conjugate vaccine (Menveo or Nimenrix) | (14.4 Vaccination) |
| | Mercilon | (7.3 Contraception) |
| | Metformin modified-release | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Methadone linctus | (16.3 Respiratory symptoms- Palliative Care) |
| | Methadone linctus | (3.4 Cough and congestion) |
| | Methadone | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Methadone | (4.5 Pain) |
| | Methenamine (oral) | (5.2 Bacterial infection) |
| | Methylcellulose | (1.2 Constipation and bowel cleansing) |
| | Methyldopa | (2.4 Blood pressure conditions) |
| | Methylnaltrexone | (1.2 Constipation and bowel cleansing) |
| | Methylnaltrexone | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Methylprednisolone (oral) | (6.2 Corticosteroid responsive conditions) |
| | Methylprednisolone (parenteral) | (6.2 Corticosteroid responsive conditions) |
| | Methylprednisolone sodium succinate | (1.1 Chronic bowel disorders) |
| | Methylprednisolone | (10.5 Soft tissue and joint disorders) |
| | Metoclopramide | (16.3 Respiratory symptoms- Palliative Care) |
| | Metolazone | (2.8 Oedema) |
| | Metoprolol | (2.4 Blood pressure conditions) |
| | Metyrapone | (6.2 Corticosteroid responsive conditions) |
| | Mezavant XL | (1.1 Chronic bowel disorders) |
| | Miconazole 2% cream (Daktarin) | (13.2 Infections of the skin) |
| | Microgynon 30 | (7.3 Contraception) |
| | Microgynon ED | (7.3 Contraception) |
| | Midazolam | (16.4 Anxiety, depression and confusion- Palliative Care) |
| | Millinette 20/75 | (7.3 Contraception) |
| | Millinette 30/75 | (7.3 Contraception) |
| | Minoxidil | (2.4 Blood pressure conditions) |
| | Mirabegron | (7.1 Bladder and urinary disorders) |
| | Mirtazapine | (16.4 Anxiety, depression and confusion- Palliative Care) |
| | Moclobemide | (4.2 Mental health disorders) |
| | Morphine | (3.4 Cough and congestion) |
| | Moxifloxacin (oral) | (5.2 Bacterial infection) |
| | Moxonidine | (2.4 Blood pressure conditions) |
| | Nabumetone | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Nadolol | (2.4 Blood pressure conditions) |
| | Naftidrofuryl oxalate | (2.9 Vascular disease) |
| | Naldemedine | (1.2 Constipation and bowel cleansing) |
| | Naloxegol | (1.2 Constipation and bowel cleansing) |
| | Naratriptan | (4.5 Pain) |
| | Nebivolol | (2.4 Blood pressure conditions) |
| | Nifedipine capsules non modified-release | (2.4 Blood pressure conditions) |
| | Nifedipine modified-release | (2.4 Blood pressure conditions) |
| | Norgeston | (7.3 Contraception) |
| | Nortriptyline | (4.5 Pain) |
| | Novorapid | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Nutrizym 22 Capsules | (1.10 Reduced exocrine secretions) |
| | Nystatin cream/ointment (Nystan) | (13.2 Infections of the skin) |
| | Octasa modified-release | (1.1 Chronic bowel disorders) |
| | Octenidine 0.3% Lotion (Octenisan) | (13.9 Skin cleansers, antiseptics and desloughing agents) |
| | Octreotide | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Ofloxacin (oral) | (5.2 Bacterial infection) |
| | Olanzapine (oral) | (4.2 Mental health disorders) |
| | Olanzapine | (16.4 Anxiety, depression and confusion- Palliative Care) |
| | Olodaterol (Striverdi Respimat) | (3.1 Airways disease, obstructive) |
| | Olodaterol / Tiotropium (inhaled) (Spiolto Respimat) | (3.1 Airways disease, obstructive) |
| | Olopatadine 1mg/mL eye drops | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Olsalazine | (1.1 Chronic bowel disorders) |
| | Omeprazole 20mg bd, Metronidazole 400mg bd and Clarithromycin 500mg bd for 1 week | (1.4 Disorders of gastric acid and ulceration) |
| | Omeprazole dispersible gastro-resistant tablets | (1.4 Disorders of gastric acid and ulceration) |
| | Omeprazole | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Ondansetron subcutaneous/intravenous injection | (16.6 End of life symptom control- Palliative Care) |
| | Ondansetron tablets / injection | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Oral morphine solution | (16.3 Respiratory symptoms- Palliative Care) |
| | Orphenadrine | (4.3 Movement disorders) |
| | Other Inhaler | (3.1 Airways disease, obstructive) |
| | Ovranette | (7.3 Contraception) |
| | Oxazepam | (4.8 Substance dependence) |
| | Oxybutynin standard-release | (7.1 Bladder and urinary disorders) |
| | Oxybutynin (transdermal) | (7.1 Bladder and urinary disorders) |
| | Oxybutynin modified release | (7.1 Bladder and urinary disorders) |
| | Oxycodone (oral) | (4.5 Pain) |
| | Oxycodone injection 50mg/mL for subcutaneous use | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Oxycodone injection | (16.6 End of life symptom control- Palliative Care) |
| | Oxycodone liquid | (16.3 Respiratory symptoms- Palliative Care) |
| | Oxycodone | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Pancrex V Capsules | (1.10 Reduced exocrine secretions) |
| | Pancrex V Powder | (1.10 Reduced exocrine secretions) |
| | Pantoprazole (intravenous) | (1.4 Disorders of gastric acid and ulceration) |
| | Paracetamol (intravenous & rectal) | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Paroxetine | (4.2 Mental health disorders) |
| | Pentasa tablets, granules modified-release | (1.1 Chronic bowel disorders) |
| | Permethrin 5% dermal cream | (13.2 Infections of the skin) |
| | Pethidine | (4.5 Pain) |
| | Phenelzine | (4.2 Mental health disorders) |
| | Phenindione | (2.3 Blood clots) |
| | Phenobarbital | (16.6 End of life symptom control- Palliative Care) |
| | Phenytoin (slow intravenous injection) | (4.6 Seizures) |
| | Phosphate | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Piracetam | (4.3 Movement disorders) |
| | Piroxicam 0.5% gel | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Pivmecillinam hydrochloride (oral) | (5.2 Bacterial infection) |
| | Pizotifen | (4.5 Pain) |
| | Potassium chloride syrup (1mmol per mL) | (9.2 Fluid and electrolyte imbalances) |
| | Potassium hydroxide solution 5% (MolluDab) | (13.2 Infections of the skin) |
| | Potassium permanganate 400mg (Permitabs) | (13.9 Skin cleansers, antiseptics and desloughing agents) |
| | Pravastatin | (2.6 Hyperlipidaemia) |
| | Prednisolone retention enema | (1.1 Chronic bowel disorders) |
| | Prednisolone suppository | (1.1 Chronic bowel disorders) |
| | Prednisolone | (16.3 Respiratory symptoms- Palliative Care) |
| | Pregabalin | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Pregabalin | (4.5 Pain) |
| | Primidone | (4.3 Movement disorders) |
| | Procyclidine | (4.3 Movement disorders) |
| | Promethazine | (3.2 Allergic conditions) |
| | Propantheline | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Propranolol | (2.4 Blood pressure conditions) |
| | Propranolol | (4.2 Mental health disorders) |
| | Propranolol | (4.3 Movement disorders) |
| | Propranolol | (6.9 Thyroid disorders) |
| | Propylthiouracil | (6.9 Thyroid disorders) |
| | Prucalopride | (1.2 Constipation and bowel cleansing) |
| | Pyridoxine | (4.6 Seizures) |
| | Qtern (Saxagliptin / Dapagliflozin) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Qtern (Saxagliptin / Dapagliflozin) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Quetiapine | (16.4 Anxiety, depression and confusion- Palliative Care) |
| | Quetiapine | (4.2 Mental health disorders) |
| | QV Skin lotion | (13.1 Dry and scaling skin disorders) |
| | Raloxifene | (6.8 Sex hormone responsive conditions) |
| | Renavit | (9.6 Vitamin deficiencies) |
| | Rimegepant | (4.5 Pain) |
| | Risedronate | (6.4 Disorders of bone metabolism) |
| | Risperidone | (16.4 Anxiety, depression and confusion- Palliative Care) |
| | Rivastigmine - includes patches | (4.1 Dementia) |
| | Rizatriptan | (4.5 Pain) |
| | Ropinirole | (4.3 Movement disorders) |
| | Rosuvastatin | (2.6 Hyperlipidaemia) |
| | Salbutamol (parenteral) | (3.1 Airways disease, obstructive) |
| | Salbutamol | (16.3 Respiratory symptoms- Palliative Care) |
| | Saliva replacement gel (Biotene Oralbalance) | (12.3 Oropharynx) |
| | Salivix pastilles | (12.3 Oropharynx) |
| | Saxagliptin | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Semaglutide (oral) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Simeticone | (16.3 Respiratory symptoms- Palliative Care) |
| | Simvastatin | (2.6 Hyperlipidaemia) |
| | Slynd | (7.3 Contraception) |
| | Sodium citrate micro-enema | (1.2 Constipation and bowel cleansing) |
| | Sodium citrate | (1.4 Disorders of gastric acid and ulceration) |
| | Sodium feredetate elixir (Sytron) | (9.1 Blood and blood–forming organs) |
| | Sodium fusidate (oral) | (5.2 Bacterial infection) |
| | Sodium hyaluronate | (11.8 Miscellaneous ophthalmic preparations) |
| | Spironolactone | (2.5 Heart Failure) |
| | Sterculia and Frangula (Normacol plus) | (1.2 Constipation and bowel cleansing) |
| | Sucralfate (oral) (unlicensed) | (1.4 Disorders of gastric acid and ulceration) |
| | Sucralfate suspension | (16.5 Mouthcare- Palliative Care) |
| | Sulpiride | (4.2 Mental health disorders) |
| | Tadalafil tablets (weekly) | (7.4 Erectile and ejaculatory conditions) |
| | Tafluprost 15microgram/mL preservative free unit dose eye drops | (11.6 Treatment of glaucoma) |
| | Tafluprost 15micrograms/mL / Timolol 5mg/mL (brands include Taptiqom) | (11.6 Treatment of glaucoma) |
| | Tamoxifen | (6.8 Sex hormone responsive conditions) |
| | Telmisartan | (2.4 Blood pressure conditions) |
| | Terbutaline (inhaled & nebulised) | (3.1 Airways disease, obstructive) |
| | Terbutaline (unlicensed) | (7.5 Obstetrics) |
| | Theophylline modified-release (oral) | (3.1 Airways disease, obstructive) |
| | Timolol 0.1% long acting preservative free eye drops (Tiopex) | (11.6 Treatment of glaucoma) |
| | Timolol 0.25% long acting eye solution (Timoptol LA) | (11.6 Treatment of glaucoma) |
| | Timolol 0.5% long acting eye solution (Timoptol LA) | (11.6 Treatment of glaucoma) |
| | Tiotropium (Spiriva Respimat) | (3.1 Airways disease, obstructive) |
| | Tirbanibulin ointment | (13.5 Photodamage) |
| | TLS Blue indications | (9.6 Vitamin deficiencies) |
| | Tolbutamide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Topiramate | (4.5 Pain) |
| | Tramadol | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Tramadol | (4.5 Pain) |
| | Travoprost 40 micrograms / Timolol 5mg/mL eye drops (brands include DuoTrav) | (11.6 Treatment of glaucoma) |
| | Trazodone | (4.2 Mental health disorders) |
| | Trifluoperazine | (4.2 Mental health disorders) |
| | Trihexyphenidyl | (4.3 Movement disorders) |
| | Trospium modified-release | (7.1 Bladder and urinary disorders) |
| | Trospium standard-release | (7.1 Bladder and urinary disorders) |
| | Tuberculin PPD RT 23 SSI, 10 T.U./0.1 mL | (14.3 Tuberculosis diagnostic test) |
| | UHB solution | (9.2 Fluid and electrolyte imbalances) |
| | Ultraveen Itch Relief cream | (13.1 Dry and scaling skin disorders) |
| | Umeclidinium (Incruse Ellipta) | (3.1 Airways disease, obstructive) |
| | Valaciclovir (oral) | (5.6 Viral infection) |
| | Verapamil modified-release | (2.4 Blood pressure conditions) |
| | Vibegron | (7.1 Bladder and urinary disorders) |
| | Vilanterol / Umeclidinium (Anoro Ellipta) | (3.1 Airways disease, obstructive) |
| | Vita-E capsules | (9.6 Vitamin deficiencies) |
| | Vitamins B & C high potency (intramuscular) (Pabrinex) | (9.6 Vitamin deficiencies) |
| | WHO solution / St Marks solution | (9.2 Fluid and electrolyte imbalances) |
| | Yacella | (7.3 Contraception) |
| | Zafirlukast | (3.1 Airways disease, obstructive) |
| | Zuclopenthixol (oral) | (4.2 Mental health disorders) |
| | Acarbose tablets | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Acetazolamide | (4.6 Seizures) |
Specialist Recommended
|
| | Aciclovir 3% eye ointment | (11.3 Anti–infective eye preparations) |
Specialist Recommended
|
| | Aerobika oscillating positive expiratory pressure device | (3.3 Conditions affecting sputum viscosity) |
Specialist Recommended
|
| | Alprostadil intracavernosal injection (Caverject, Viridal Duo) | (7.4 Erectile and ejaculatory conditions) |
Specialist Recommended
|
| | Alprostadil urethral application (Muse) | (7.4 Erectile and ejaculatory conditions) |
Specialist Recommended
|
| | Alprostadil urethral cream (Vitaros) | (7.4 Erectile and ejaculatory conditions) |
Specialist Recommended
|
| | Amantadine | (4.3 Movement disorders) |
3 month
Specialist Initiated
|
| | Amiodarone (oral) | (2.1 Arrhythmias) |
|
| | Anastrozole (oral) | (8.2 Malignant disease) |
Specialist Recommended
|
| | Apraclonidine 0.5% eye drops | (11.6 Treatment of glaucoma) |
Specialist Recommended
|
| | Atogepant | (4.5 Pain) |
Specialist Initiated
|
| | Atomoxetine | (4.2 Mental health disorders) |
3 month
|
| | Aviptadil / Phentolamine (Invicorp) | (7.4 Erectile and ejaculatory conditions) |
Specialist Recommended
|
| | Azathioprine (oral & parenteral) | (8.1 Immune system) |
3 month
|
| | Azathioprine (oral) | (1.7 Liver disorders and related conditions) |
3 month
|
| | Azathioprine (oral) | (13.3 Inflammatory skin conditions) |
3 month
|
| | Azathioprine IBD | (1.1 Chronic bowel disorders) |
1 month
|
| | Azathioprine | (10.1 Arthritis) |
1 month
|
| | Azathioprine | (11.4 Corticosteroids and other anti–inflammatory preparations) |
1 month
|
| | Azathioprine | (3.5 Interstitial Lung Disease) |
1 month
|
| | Betamethasone soluble tablets | (12.3 Oropharynx) |
Specialist Recommended
|
| | Bicalutamide (oral) | (8.2 Malignant disease) |
1 month
|
| | Bismuth chelate | (1.4 Disorders of gastric acid and ulceration) |
Specialist Recommended
|
| | Brivaracetam | (4.6 Seizures) |
Specialist Initiated
|
| | Bromocriptine | (6.5 Dopamine responsive conditions) |
3 month
|
| | Budesonide (Budenofalk) (oral) | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Budesonide MMX (Cortiment) prolonged release tablets | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Budesonide orodispersible tablets | (1.4 Disorders of gastric acid and ulceration) |
3 month
|
| | Buserelin nasal spray | (6.6 Gonadotrophin responsive conditions) |
Specialist Recommended
|
| | Cabergoline | (4.3 Movement disorders) |
Specialist Initiated
|
| | Cabergoline | (6.5 Dopamine responsive conditions) |
3 month
|
| | Carbamazepine | (4.2 Mental health disorders) |
Specialist Initiated
|
| | Carbamazepine | (4.6 Seizures) |
Specialist Recommended
|
| | Cenobamate | (4.6 Seizures) |
Specialist Initiated
|
| | Ciclosporin 1mg/mL eye drops (Ikervis) | (11.8 Miscellaneous ophthalmic preparations) |
3 month
|
| | Cinacalcet | (9.2 Fluid and electrolyte imbalances) |
3 month
|
| | Clobazam | (4.6 Seizures) |
Specialist Recommended
|
| | Clonazepam | (4.6 Seizures) |
Specialist Recommended
|
| | Colesevelam | (1.7 Liver disorders and related conditions) |
1 month
|
| | Colistimethate sodium (injection to be used via nebuliser) | (3.1 Airways disease, obstructive) |
3 month
|
| | Colistimethate sodium (injection to be used via nebuliser) | (5.2 Bacterial infection) |
3 month
|
| | Cyproterone (oral) | (8.2 Malignant disease) |
|
| | Dalteparin | (2.3 Blood clots) |
|
| | Danazol | (6.6 Gonadotrophin responsive conditions) |
Specialist Initiated
|
| | Dapagliflozin | (2.5 Heart Failure) |
Specialist Recommended
|
| | Dapsone (oral) | (12.3 Oropharynx) |
3 month
|
| | Dapsone (oral) | (13.3 Inflammatory skin conditions) |
3 month
|
| | Degarelix (Firmagon) (subcutaneous) | (8.2 Malignant disease) |
1 month
|
| | Denosumab | (6.4 Disorders of bone metabolism) |
3 month
|
| | Dequalinium chloride (Fluomizin 10mg vaginal tablets) | (7.6 Vaginal and vulval conditions) |
Specialist Recommended
|
| | Desmopressin (Noqdirna) | (7.1 Bladder and urinary disorders) |
3 month
|
| | Dexamethasone soluble tablets (oral rinse) | (12.3 Oropharynx) |
Specialist Recommended
|
| | Dexamfetamine | (4.2 Mental health disorders) |
3 month
|
| | Dexamfetamine | (4.7 Sleep disorders) |
3 month
|
| | Dienogest tablets | (6.8 Sex hormone responsive conditions) |
Specialist Recommended
|
| | Doxepin 5% cream | (4.5 Pain) |
Specialist Recommended
|
| | Dronedarone | (2.1 Arrhythmias) |
3 month
|
| | Duloxetine | (7.1 Bladder and urinary disorders) |
Specialist Recommended
|
| | Empagliflozin | (2.5 Heart Failure) |
Specialist Recommended
|
| | Enoxaparin | (2.3 Blood clots) |
|
| | Entacapone | (4.3 Movement disorders) |
Specialist Recommended
|
| | Eplerenone | (2.5 Heart Failure) |
Specialist Recommended
|
| | Ertapenem (parenteral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Eslicarbazepine | (4.6 Seizures) |
Specialist Initiated
|
| | Ethosuximide | (4.6 Seizures) |
Specialist Recommended
|
| | Exemestane (oral) | (8.2 Malignant disease) |
Specialist Recommended
|
| | Fiasp | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Fidaxomicin (oral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Finerenone | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Flecainide (oral) | (2.1 Arrhythmias) |
Specialist Recommended
|
| | Fluocinolone Acetonide 0.025% gel (Synalar) (oral) | (12.3 Oropharynx) |
Specialist Recommended
|
| | Flupentixol decanoate | (4.2 Mental health disorders) |
1 month
|
| | Fluphenazine decanoate | (4.2 Mental health disorders) |
1 month
|
| | Fosfomycin (oral & parenteral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Gabapentin | (4.6 Seizures) |
Specialist Recommended
|
| | Ganciclovir 0.15% eye gel | (11.3 Anti–infective eye preparations) |
Specialist Recommended
|
| | Gentamicin (nebulised) | (5.2 Bacterial infection) |
3 month
|
| | Glycopyrronium bromide | (12.3 Oropharynx) |
3 month
|
| | Goserelin (Zoladex) | (6.6 Gonadotrophin responsive conditions) |
|
| | Guanfacine modified release tablets | (4.2 Mental health disorders) |
3 month
|
| | Haloperidol decanoate | (4.2 Mental health disorders) |
1 month
|
| | Humalog Mix 25 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Humalog Mix 50 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Hydrocortisone (Efmody) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Hydroxycarbamide (oral - capsules) | (8.2 Malignant disease) |
3 month
|
| | Hydroxychloroquine (oral) | (13.3 Inflammatory skin conditions) |
1 month
|
| | Hydroxychloroquine | (10.1 Arthritis) |
1 month
|
| | Hypertonic Sodium chloride 3% or 6% or 7% | (3.3 Conditions affecting sputum viscosity) |
Specialist Initiated
|
| | Ibandronic acid 50mg tablet | (6.4 Disorders of bone metabolism) |
3 month
|
| | Ivabradine | (2.7 Myocardial ischaemia) |
3 month
|
| | Ketorolac subcutaneous injection | (16.1 Pain due to cancer in adults- Palliative Care) |
Specialist Recommended
|
| | Lacosamide | (4.5 Pain) |
3 month
|
| | Lacosamide | (4.6 Seizures) |
3 month
|
| | Lamotrigine | (4.2 Mental health disorders) |
Specialist Recommended
|
| | Lamotrigine | (4.6 Seizures) |
Specialist Recommended
|
| | Lanthanum | (9.2 Fluid and electrolyte imbalances) |
Specialist Recommended
|
| | Lecicarbon A suppositories | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Leflunomide | (10.1 Arthritis) |
1 month
|
| | Letrozole (oral) | (8.2 Malignant disease) |
Specialist Recommended
|
| | Leuprorelin (e.g. Staladex, Prostap) | (6.6 Gonadotrophin responsive conditions) |
Specialist Recommended
|
| | Leuprorelin (Prostap) | (6.6 Gonadotrophin responsive conditions) |
3 month
Specialist Recommended
|
| | Levetiracetam (parenteral) | (4.6 Seizures) |
Specialist Recommended
|
| | Levetiracetam | (4.6 Seizures) |
Specialist Recommended
|
| | Levodopa / Carbidopa / Entacapone | (4.3 Movement disorders) |
Specialist Recommended
|
| | Lidocaine patch | (4.5 Pain) |
Specialist Recommended
|
| | Lidocaine patches | (16.1 Pain due to cancer in adults- Palliative Care) |
Specialist Recommended
|
| | Linaclotide | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Linzagolix | (7.3 Contraception) |
Specialist Initiated
|
| | Lisdexamfetamine | (4.2 Mental health disorders) |
3 month
|
| | Lithium carbonate modified-release | (4.2 Mental health disorders) |
3 month
|
| | Lithium citrate liquid | (4.2 Mental health disorders) |
3 month
|
| | Loteprednol 0.5% eye drops | (11.4 Corticosteroids and other anti–inflammatory preparations) |
Specialist Recommended
|
| | Lyumjev | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Melatonin modified-release and immediate-release | (4.7 Sleep disorders) |
3 month
|
| | Mercaptopurine (oral) | (1.7 Liver disorders and related conditions) |
3 month
|
| | Mercaptopurine (oral) | (8.1 Immune system) |
3 month
|
| | Mercaptopurine IBD | (1.1 Chronic bowel disorders) |
1 month
|
| | Methotrexate (oral & subcutaneous) | (13.3 Inflammatory skin conditions) |
3 month
|
| | Methotrexate (oral) 2.5mg tablets only - weekly dose | (10.1 Arthritis) |
1 month
|
| | Methotrexate (oral) | (8.2 Malignant disease) |
|
| | Methotrexate (parenteral) - weekly dose | (10.1 Arthritis) |
1 month
|
| | Methotrexate | (4.3 Movement disorders) |
3 month
|
| | Methotrexate IBD | (1.1 Chronic bowel disorders) |
1 month
|
| | Methotrexate | (11.4 Corticosteroids and other anti–inflammatory preparations) |
1 month
|
| | Methotrexate | (3.5 Interstitial Lung Disease) |
1 month
|
| | Methylphenidate modified-release and immediate-release | (4.2 Mental health disorders) |
3 month
|
| | Midodrine | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Minocycline (oral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Modafinil | (4.7 Sleep disorders) |
3 month
|
| | Mycophenolate (oral) | (13.3 Inflammatory skin conditions) |
3 month
|
| | Mycophenolate (oral) | (10.1 Arthritis) |
3 month
|
| | Mycophenolate mofetil (oral) | (1.7 Liver disorders and related conditions) |
3 month
|
| | Mycophenolate mofetil / Mycophenolic acid (oral) | (8.1 Immune system) |
3 month
|
| | Mycophenolate | (1.1 Chronic bowel disorders) |
3 month
|
| | Mycophenolate | (10.3 Neuromuscular disorders) |
3 month
|
| | Mycophenolate | (11.4 Corticosteroids and other anti–inflammatory preparations) |
3 month
|
| | Mycophenolate | (3.5 Interstitial Lung Disease) |
3 month
|
| | n® o | (6.4 Disorders of bone metabolism) |
Specialist Initiated
|
| | Nalmefene | (4.8 Substance dependence) |
Specialist Recommended
|
| | Naltrexone | (4.8 Substance dependence) |
1 month
|
| | Novomix 30 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Opicapone | (4.3 Movement disorders) |
3 month
|
| | Ospemifene tablets | (7.6 Vaginal and vulval conditions) |
Specialist Recommended
|
| | Oxcarbazepine | (4.6 Seizures) |
3 month
|
| | Patiromer | (9.2 Fluid and electrolyte imbalances) |
Specialist Initiated
|
| | Penicillamine | (10.1 Arthritis) |
1 month
|
| | Penicillamine | (9.3 Metabolic disorders) |
3 month
|
| | Perampanel | (4.6 Seizures) |
Specialist Initiated
|
| | Phenobarbital | (4.6 Seizures) |
Specialist Recommended
|
| | Phenytoin | (4.6 Seizures) |
Specialist Recommended
|
| | Pilocarpine tablets | (12.3 Oropharynx) |
Specialist Recommended
|
| | Potassium Chloride 600mg (8mmol) modified release tablets | (9.2 Fluid and electrolyte imbalances) |
Specialist Recommended
|
| | Pramipexole (including modified-release) | (4.3 Movement disorders) |
Specialist Initiated
|
| | Prasugrel | (2.7 Myocardial ischaemia) |
1 month
|
| | Pregabalin | (4.6 Seizures) |
Specialist Initiated
|
| | Primidone | (4.6 Seizures) |
Specialist Recommended
|
| | Propafenone (oral) | (2.1 Arrhythmias) |
Specialist Recommended
|
| | Pyridoxine hydrochloride / doxylamine succinate (Xonvea) tablets | (4.4 Nausea and labyrinth disorders) |
Specialist Initiated
|
| | Qlaira (estradiol valerate / dienogest) | (7.3 Contraception) |
Specialist Recommended
|
| | Ranolazine | (2.7 Myocardial ischaemia) |
1 month
|
| | Rasagiline | (4.3 Movement disorders) |
Specialist Initiated
|
| | Relugolix (Orgovyx) (oral) | (8.2 Malignant disease) |
Specialist Initiated
|
| | Relugolix-estradiol-norethisterone acetate (Ryeqo | (7.3 Contraception) |
Specialist Initiated
|
| | Rifampicin (oral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Rifaximin (oral) | (5.2 Bacterial infection) |
Specialist Initiated
|
| | Riluzole | (4.3 Movement disorders) |
3 month
|
| | Rimegepant | (4.5 Pain) |
Specialist Initiated
|
| | Rivaroxaban | (2.3 Blood clots) |
1 month
3 month
|
| | Roflumilast | (3.1 Airways disease, obstructive) |
Specialist Initiated
|
| | Ropinirole (including modified-release & starter pack) | (4.3 Movement disorders) |
Specialist Initiated
|
| | Rotigotine | (4.3 Movement disorders) |
Specialist Recommended
|
| | Rufinamide | (4.6 Seizures) |
Specialist Initiated
|
| | Sacubitril / Valsartan (Entresto) | (2.5 Heart Failure) |
1 month
|
| | Safinamide | (4.3 Movement disorders) |
3 month
|
| | Selegiline | (4.3 Movement disorders) |
Specialist Initiated
|
| | Sevelamer | (9.2 Fluid and electrolyte imbalances) |
Specialist Recommended
|
| | Sildenafil | (10.1 Arthritis) |
3 month
|
| | Silicone Gel | (13.13 Miscellaneous skin preparations) |
Specialist Recommended
|
| | Sodium valproate / Valproic acid (Depakote) | (4.2 Mental health disorders) |
3 month
|
| | Sodium valproate | (4.5 Pain) |
3 month
|
| | Sodium zirconium cyclosilicate | (9.2 Fluid and electrolyte imbalances) |
Specialist Initiated
|
| | Spironolactone (oral) | (13.7 Rosacea and acne) |
Specialist Initiated
|
| | Spironolactone (oral) | (13.3 Inflammatory skin conditions) |
Specialist Initiated
|
| | Sucralfate 2g/50mL enema | (1.4 Disorders of gastric acid and ulceration) |
Specialist Recommended
|
| | Sucroferric oxyhydroxide | (9.2 Fluid and electrolyte imbalances) |
Specialist Recommended
|
| | Sulfasalazine | (1.1 Chronic bowel disorders) |
1 month
|
| | Sulfasalazine | (10.1 Arthritis) |
1 month
|
| | Tadalafil 5mg tablets (once daily) | (7.4 Erectile and ejaculatory conditions) |
Specialist Initiated
|
| | Tamoxifen (oral) | (8.2 Malignant disease) |
Specialist Recommended
|
| | Tapentadol modified-release | (4.5 Pain) |
3 month
|
| | Testosterone gel (Tostran 2% gel / Testogel 40.5mg/2.5g gel sachets) | (6.8 Sex hormone responsive conditions) |
3 month
|
| | Testosterone oily injection (Nebido® and Sustanon 250) | (6.8 Sex hormone responsive conditions) |
3 month
|
| | Tetrabenazine | (4.3 Movement disorders) |
Specialist Initiated
|
| | Tiagabine | (4.6 Seizures) |
Specialist Recommended
|
| | Ticagrelor | (2.7 Myocardial ischaemia) |
1 month
|
| | Tinzaparin | (2.3 Blood clots) |
|
| | Tiotropium (Respimat) | (3.1 Airways disease, obstructive) |
Specialist Recommended
|
| | Tobramycin (nebulised) | (3.1 Airways disease, obstructive) |
3 month
|
| | Tobramycin (nebulised) | (5.2 Bacterial infection) |
3 month
|
| | Topiramate | (4.6 Seizures) |
Specialist Recommended
|
| | Toujeo Solostar U300 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Toujeo | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Tresiba U100 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Tresiba U200 | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Tresiba | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Triptorelin (Decapeptyl SR) | (6.6 Gonadotrophin responsive conditions) |
Specialist Recommended
|
| | Vardenafil | (7.4 Erectile and ejaculatory conditions) |
Specialist Recommended
|
| | Verapamil (immediate release tablets) | (4.5 Pain) |
3 month
|
| | VisuXL Gel | (11.8 Miscellaneous ophthalmic preparations) |
Specialist Recommended
|
| | Vitamin A+D | (9.6 Vitamin deficiencies) |
Specialist Recommended
|
| | Vortioxetine | (4.2 Mental health disorders) |
Specialist Recommended
|
| | Zonisamide | (4.6 Seizures) |
Specialist Initiated
|
| | Zuclopenthixol decanoate | (4.2 Mental health disorders) |
1 month
|
| | 5-aminolaevulinic acid gel (Ameluz) | (13.5 Photodamage) |
| | Abacavir (oral) | (5.6 Viral infection) |
| | Abacavir / Dolutegravir / Lamivudine (oral) (Triumeq) | (5.6 Viral infection) |
| | Abaloparatide | (6.4 Disorders of bone metabolism) |
| | Abatacept | (10.1 Arthritis) |
| | Abemaciclib (oral) | (8.2 Malignant disease) |
| | Abiraterone (oral) | (8.2 Malignant disease) |
| | Abrocitinib (oral) | (13.3 Inflammatory skin conditions) |
| | Acalabrutinib (oral) | (8.2 Malignant disease) |
| | Acarizax (oral) | (3.2 Allergic conditions) |
| | Acetic acid solution | (1.4 Disorders of gastric acid and ulceration) |
| | Acetylcholine | (2.7 Myocardial ischaemia) |
| | Acetylcysteine (unlicensed) | (3.3 Conditions affecting sputum viscosity) |
| | Acetylcysteine 10% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Aciclovir (parenteral) | (5.6 Viral infection) |
| | Acid citrate dextrose | (17.1 Miscellaneous Preparations) |
| | Acitretin | (13.3 Inflammatory skin conditions) |
| | Actilyse Cathflo | (2.7 Myocardial ischaemia) |
| | Adalimumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Adalimumab | (1.1 Chronic bowel disorders) |
| | Adalimumab | (10.1 Arthritis) |
| | Adalimumab | (11.8 Miscellaneous ophthalmic preparations) |
| | Addaven | (9.4 Trace element deficiencies) |
| | Adefovir dipivoxil (oral) | (5.6 Viral infection) |
| | Adenosine | (2.1 Arrhythmias) |
| | Adrenaline (epinephrine) 1 in 10,000 (100micrograms/mL) | (2.4 Blood pressure conditions) |
| | Afatinib (oral) | (8.2 Malignant disease) |
| | Aflibercept | (11.8 Miscellaneous ophthalmic preparations) |
| | Ajmaline | (2.1 Arrhythmias) |
| | Albendazole (oral) (unlicensed) | (5.4 Helminth infection) |
| | Aldesleukin (parenteral) | (8.2 Malignant disease) |
| | Alectinib (oral) | (8.2 Malignant disease) |
| | Alemtuzumab (parenteral) | (8.1 Immune system) |
| | Alfacalcidol (parenteral) | (9.6 Vitamin deficiencies) |
| | Alfentanil injection | (4.5 Pain) |
| | Alfentanil intranasal | (4.5 Pain) |
| | Alfentanil | (15.1 General Anaesthesia) |
| | Alirocumab | (2.6 Hyperlipidaemia) |
| | Aliskiren | (2.4 Blood pressure conditions) |
| | Alitretinoin | (13.3 Inflammatory skin conditions) |
| | All intravenous nutrition | (9.5 Nutrition) |
| | Alpelisib (oral) | (8.2 Malignant disease) |
| | Alteplase (For all indications except acute MI) | (2.7 Myocardial ischaemia) |
| | Alteplase | (2.3 Blood clots) |
| | Aluminium acetate 13% drops | (12.1 Ear) |
| | Alutard | (3.2 Allergic conditions) |
| | Ambrisentan (oral) | (2.4 Blood pressure conditions) |
| | Amikacin (intravesical) | (5.2 Bacterial infection) |
| | Amikacin (nebulised) | (5.2 Bacterial infection) |
| | Amikacin (parenteral) | (5.2 Bacterial infection) |
| | Amikacin 35mg/mL (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Aminophylline (parenteral) | (3.1 Airways disease, obstructive) |
| | Amiodarone (intravenous) | (2.1 Arrhythmias) |
| | Amphotericin 0.15% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Amsacrine (parenteral) | (8.2 Malignant disease) |
| | Anagrelide | (9.1 Blood and blood–forming organs) |
| | Anakinra | (10.1 Arthritis) |
| | Anakinra | (8.1 Immune system) |
| | Andexanet Alfa | (2.3 Blood clots) |
| | Anidulafungin (parenteral) | (5.3 Fungal infection) |
| | Anti-D (Rho) immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Antithymocyte globulin (ATG) (horse) | (8.1 Immune system) |
| | Antithymocyte globulin (ATG) (rabbit) | (8.1 Immune system) |
| | Apalutamide | (8.2 Malignant disease) |
| | Apixaban | (2.3 Blood clots) |
| | Apomorphine | (4.3 Movement disorders) |
| | Apremilast | (10.1 Arthritis) |
| | Apremilast | (13.3 Inflammatory skin conditions) |
| | Aprepitant | (4.4 Nausea and labyrinth disorders) |
| | Aqueous Iodine Oral Solution (Lugol's Solution) | (6.9 Thyroid disorders) |
| | Argatroban | (2.3 Blood clots) |
| | Arsenic trioxide (parenteral) | (8.2 Malignant disease) |
| | Artemether / Lumefantrine (oral) (Riamet) | (5.5 Protozoal infection) |
| | Artesunate (parenteral) (unlicensed) | (5.5 Protozoal infection) |
| | Asciminib (oral) | (8.2 Malignant disease) |
| | Atazanavir (oral) | (5.6 Viral infection) |
| | Atazanavir / Cobicistat (Evotaz) | (5.6 Viral infection) |
| | Atezolizumab (parenteral) | (8.2 Malignant disease) |
| | Atosiban | (7.5 Obstetrics) |
| | Atovaquone (oral) | (5.3 Fungal infection) |
| | Atracurium | (15.1 General Anaesthesia) |
| | Autologous anti-CD19-transduced CD3+ cells | (8.2 Malignant disease) |
| | Autologous chondrocyte implantation | (17.1 Miscellaneous Preparations) |
| | Avacopan | (2.9 Vascular disease) |
| | Avapritinib | (8.2 Malignant disease) |
| | Avatrombopag | (9.1 Blood and blood–forming organs) |
| | Avelumab (parenteral) | (8.2 Malignant disease) |
| | Axicabtagene ciloleucel | (8.2 Malignant disease) |
| | Axitinib (oral) | (8.2 Malignant disease) |
| | Azacitidine | (8.2 Malignant disease) |
| | Azathioprine (oral & parenteral) | (8.1 Immune system) |
| | Azithromycin 1.5% eye drops | (11.3 Anti–infective eye preparations) |
| | Aztreonam (nebulised) | (5.2 Bacterial infection) |
| | Baclofen (intrathecal) | (10.3 Neuromuscular disorders) |
| | Baricitinib | (10.1 Arthritis) |
| | Baricitinib | (13.3 Inflammatory skin conditions) |
| | Baricitinib | (5.7 Treatment of COVID-19) |
| | Basiliximab (parenteral) | (8.1 Immune system) |
| | BCG bladder irrigation (instillation) | (8.2 Malignant disease) |
| | Bedaquiline (oral) | (5.2 Bacterial infection) |
| | Belimumab | (10.1 Arthritis) |
| | Belimumab | (8.1 Immune system) |
| | Belumosudil | (8.1 Immune system) |
| | Belzutifan | (8.2 Malignant disease) |
| | Bendamustine (parenteral) | (8.2 Malignant disease) |
| | Benralizumab | (3.1 Airways disease, obstructive) |
| | Benzathine benzylpenicillin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Beriplex P/N (dried prothrombin complex) | (2.2 Bleeding disorders) |
| | Berotralstat | (3.2 Allergic conditions) |
| | Betaine | (9.3 Metabolic disorders) |
| | Bevacizumab (intravitreal) | (8.2 Malignant disease) |
| | Bevacizumab (parenteral) | (8.2 Malignant disease) |
| | Bevacizumab | (11.8 Miscellaneous ophthalmic preparations) |
| | Bexarotene (oral) | (8.2 Malignant disease) |
| | Bictegravir / Emtricitabine / Tenofovir Alafenamide (oral) (Biktarvy) | (5.6 Viral infection) |
| | Bimekizumab | (10.1 Arthritis) |
| | Bimekizumab | (13.3 Inflammatory skin conditions) |
| | Bismuth subnitrate and Iodoform (BIPP) paste | (12.2 Nose) |
| | Bivalirudin | (2.3 Blood clots) |
| | Bleomycin (IV) electrochemotherapy treatment | (8.2 Malignant disease) |
| | Bleomycin (parenteral) | (8.2 Malignant disease) |
| | Bleomycin | (2.9 Vascular disease) |
| | Blinatumomab | (8.2 Malignant disease) |
| | Bone morphogenetic protein (Inductos, Osigraft) | (17.1 Miscellaneous Preparations) |
| | Bortezomib (parenteral) | (8.2 Malignant disease) |
| | Bosentan (oral) | (2.4 Blood pressure conditions) |
| | Bosutinib (parenteral) | (8.2 Malignant disease) |
| | Botulinum toxin type A (Botox, Dysport, Xeomin) | (4.3 Movement disorders) |
| | Botulinum toxin type A | (11.8 Miscellaneous ophthalmic preparations) |
| | Botulinum toxin type A | (4.5 Pain) |
| | Botulinum toxin type A | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Botulinum toxin type A | (1.9 Rectal and anal disorders) |
| | Botulinum toxin type A | (12.3 Oropharynx) |
| | Botulinum toxin type A | (4.5 Pain) |
| | Botulinum toxin type A | (7.1 Bladder and urinary disorders) |
| | Botulinum toxin type B (Neurobloc) | (4.3 Movement disorders) |
| | Botulism antitoxin | (14.2 Post-exposure prophylaxis) |
| | Brentuximab (parenteral) | (8.2 Malignant disease) |
| | Brexucabtagene autoleucel | (8.2 Malignant disease) |
| | Brigatinib (oral) | (8.2 Malignant disease) |
| | Brodalumab | (13.3 Inflammatory skin conditions) |
| | Brolucizumab | (11.8 Miscellaneous ophthalmic preparations) |
| | Budesonide (Targeted-release) | (6.2 Corticosteroid responsive conditions) |
| | Budesonide orodispersible tablets | (1.4 Disorders of gastric acid and ulceration) |
| | Bulevirtide | (5.6 Viral infection) |
| | Bupivacaine 0.1% / Fentanyl 2micrograms/mL | (15.2 Local anaesthesia) |
| | Bupivacaine 0.1% for epidural infusion | (15.2 Local anaesthesia) |
| | Bupivacaine 0.25% / Adrenaline 1 in 200,000 injection | (15.2 Local anaesthesia) |
| | Bupivacaine 0.25% & 0.5% injection | (15.2 Local anaesthesia) |
| | Bupivacaine 0.5% / Adrenaline 1 in 200,000 injection | (15.2 Local anaesthesia) |
| | Bupivacaine 5mg / Glucose 80mg/mL injection | (15.2 Local anaesthesia) |
| | Burosumab | (9.2 Fluid and electrolyte imbalances) |
| | Buserelin nasal spray | (6.6 Gonadotrophin responsive conditions) |
| | Busulfan (Busulphan) (oral & parenteral) | (8.2 Malignant disease) |
| | C1-esterase inhibitor (Berinert, Cinryze) | (3.2 Allergic conditions) |
| | Cabazitaxel (parenteral) | (8.2 Malignant disease) |
| | Cabotegravir with Rilpivirine | (5.6 Viral infection) |
| | Cabozantinib (oral) | (8.2 Malignant disease) |
| | Cacicol | (11.8 Miscellaneous ophthalmic preparations) |
| | Calcitonin salmon (salcatonin) injection | (6.4 Disorders of bone metabolism) |
| | Calcitriol (parenteral) | (9.6 Vitamin deficiencies) |
| | Canakinumab | (8.1 Immune system) |
| | Cangrelor | (2.7 Myocardial ischaemia) |
| | Cannabidiol (Epidyolex) | (4.6 Seizures) |
| | Capecitabine (oral) | (8.2 Malignant disease) |
| | Caphosol mouthwash | (12.3 Oropharynx) |
| | Caplacizumab (parenteral) | (8.2 Malignant disease) |
| | Capsaicin patch (Qutenza) | (4.5 Pain) |
| | Carbetocin | (7.5 Obstetrics) |
| | Carbidopa + Levodopa + Entacapone intestinal gel (Lecigon) | (4.3 Movement disorders) |
| | Carbidopa + Levodopa intestinal gel (Duodopa) | (4.3 Movement disorders) |
| | Carboplatin (parenteral) | (8.2 Malignant disease) |
| | Carboprost | (7.5 Obstetrics) |
| | Carfilzomib | (8.2 Malignant disease) |
| | Carmustine implant (parenteral) (Glidael) | (8.2 Malignant disease) |
| | Carnitine | (9.3 Metabolic disorders) |
| | Casirivimab and Imdevimab | (5.7 Treatment of COVID-19) |
| | Caspofungin (parenteral) | (5.3 Fungal infection) |
| | Cefazolin (parenteral) | (5.2 Bacterial infection) |
| | Cefiderocol (parenteral) | (5.2 Bacterial infection) |
| | Cefoxitin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Ceftazidime (parenteral) | (5.2 Bacterial infection) |
| | Ceftazidime / Avibactam (parenteral) | (5.2 Bacterial infection) |
| | Ceftolozane & Tazobactam (parenteral) | (5.2 Bacterial infection) |
| | Cefuroxime (parenteral) | (5.2 Bacterial infection) |
| | Cefuroxime 5% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Cefuroxime injection (Aprokam) | (11.3 Anti–infective eye preparations) |
| | Cemiplimab (parenteral) | (8.2 Malignant disease) |
| | Ceritinib (oral) | (8.2 Malignant disease) |
| | Cernevit | (9.6 Vitamin deficiencies) |
| | Certolizumab pegol (parenteral) | (13.3 Inflammatory skin conditions) |
| | Certolizumab pegol | (10.1 Arthritis) |
| | Cetuximab (parenteral) | (8.2 Malignant disease) |
| | Chenodeoxycholic Acid | (1.7 Liver disorders and related conditions) |
| | Chlorambucil (oral) | (8.2 Malignant disease) |
| | Chloramphenicol (oral & parenteral) | (5.2 Bacterial infection) |
| | Chlorhexidine 0.02% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Chlorhexidine 0.2% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Chlormethine gel | (8.2 Malignant disease) |
| | Chloroprocaine solution | (15.2 Local anaesthesia) |
| | Chloroquine (oral) | (5.5 Protozoal infection) |
| | Cholic Acid | (1.7 Liver disorders and related conditions) |
| | Chorionic gonadotropin | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Ciclosporin (oral & parenteral) | (8.1 Immune system) |
| | Ciclosporin (oral) | (13.3 Inflammatory skin conditions) |
| | Ciclosporin 0.2% eye ointment (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Ciclosporin | (1.1 Chronic bowel disorders) |
| | Ciclosporin | (10.1 Arthritis) |
| | Cidofovir (parenteral) | (5.6 Viral infection) |
| | Cinacalcet | (9.2 Fluid and electrolyte imbalances) |
| | Ciprofloxacin (parenteral) | (5.2 Bacterial infection) |
| | Cisatracurium | (15.1 General Anaesthesia) |
| | Cisplatin (parenteral) | (8.2 Malignant disease) |
| | Cladribine (oral) | (8.1 Immune system) |
| | Cladribine (parenteral) | (8.2 Malignant disease) |
| | Clarithromycin (parenteral) | (5.2 Bacterial infection) |
| | Clindamycin (oral & parenteral) | (5.3 Fungal infection) |
| | Clindamycin (parenteral) | (5.2 Bacterial infection) |
| | Clofarabine (parenteral) | (8.2 Malignant disease) |
| | Clofazimine (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Clonazepam (parenteral) | (4.6 Seizures) |
| | Clonidine | (15.1 General Anaesthesia) |
| | Clozapine | (4.2 Mental health disorders) |
| | CMV immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Co-amoxiclav (parenteral) | (5.2 Bacterial infection) |
| | Co-trimoxazole (parenteral) | (5.2 Bacterial infection) |
| | Co-trimoxazole (parenteral) | (5.3 Fungal infection) |
| | Cobicistat / Darunavir / Emtricitabine / Tenofovir (oral) (Symtuza) | (5.6 Viral infection) |
| | Cocaine 10% solution | (15.2 Local anaesthesia) |
| | Cocaine 5% / Adrenaline 1:2000 gel | (15.2 Local anaesthesia) |
| | Cocaine 5% solution | (15.2 Local anaesthesia) |
| | Colistimethate sodium (injection to be used via nebuliser) | (3.1 Airways disease, obstructive) |
| | Colistimethate sodium (injection to be used via nebuliser) | (5.2 Bacterial infection) |
| | Colistimethate sodium (parenteral) | (5.2 Bacterial infection) |
| | Colistimethate sodium Dry Powder Inhaler (inhaled) | (3.1 Airways disease, obstructive) |
| | Colistimethate sodium Dry Powder Inhaler (inhaled) | (5.2 Bacterial infection) |
| | Colobreathe 1,662,500unit inhalation powder capsules (inhaled) | (3.1 Airways disease, obstructive) |
| | Conestat alfa (Ruconest) | (3.2 Allergic conditions) |
| | Crisantaspase (parenteral) | (8.2 Malignant disease) |
| | Crizotinib (oral) | (8.2 Malignant disease) |
| | Cyclophosphamide (oral & parenteral) | (8.2 Malignant disease) |
| | Cyclophosphamide | (10.1 Arthritis) |
| | Cycloserine (oral) | (5.2 Bacterial infection) |
| | Cyproterone | (6.8 Sex hormone responsive conditions) |
| | Cytarabine (parenteral) | (8.2 Malignant disease) |
| | Dabigatran | (2.3 Blood clots) |
| | Dabrafenib (parenteral) | (8.2 Malignant disease) |
| | Dacarbazine (parenteral) | (8.2 Malignant disease) |
| | Dacomitinib (oral) | (8.2 Malignant disease) |
| | Dactinomycin (parenteral) | (8.2 Malignant disease) |
| | Dalbavancin (parenteral) | (5.2 Bacterial infection) |
| | Danaparoid | (2.3 Blood clots) |
| | Dantrolene | (15.1 General Anaesthesia) |
| | Dapsone (oral) | (5.2 Bacterial infection) |
| | Dapsone (oral) | (5.3 Fungal infection) |
| | Daptomycin (parenteral) | (5.2 Bacterial infection) |
| | Daratumumab (parenteral) | (8.2 Malignant disease) |
| | Darbepoetin alfa | (9.1 Blood and blood–forming organs) |
| | Darolutamide (oral) | (8.2 Malignant disease) |
| | Darunavir (oral) | (5.6 Viral infection) |
| | Darunavir / Cobicistat (Rezolsta) | (5.6 Viral infection) |
| | Dasatinib (oral) | (8.2 Malignant disease) |
| | Daunorubicin (parenteral) | (8.2 Malignant disease) |
| | Deferasirox | (9.1 Blood and blood–forming organs) |
| | Deferiprone | (9.1 Blood and blood–forming organs) |
| | Defibrotide | (2.3 Blood clots) |
| | Delamanid (oral) | (5.2 Bacterial infection) |
| | Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) (Sativex) oromucosal spray | (10.3 Neuromuscular disorders) |
| | Denosumab | (6.4 Disorders of bone metabolism) |
| | Dequalinium chloride (Fluomizin 10mg vaginal tablets) | (7.6 Vaginal and vulval conditions) |
| | Dermovate with 40% Propylene glycol | (13.3 Inflammatory skin conditions) |
| | Desferrioxamine | (9.1 Blood and blood–forming organs) |
| | Desferrioxamine | (9.1 Blood and blood–forming organs) |
| | Deucravacitinib | (13.3 Inflammatory skin conditions) |
| | Dexamethasone intravitreal implant 700micrograms (Ozurdex) | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Dexmedetomidine | (15.1 General Anaesthesia) |
| | Diazepam (parenteral) | (4.6 Seizures) |
| | Diazepam rectal tubes | (4.6 Seizures) |
| | Diazoxide | (2.4 Blood pressure conditions) |
| | Dibotermin alfa | (10.5 Soft tissue and joint disorders) |
| | Diclofenac 0.1% preservative free eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Didanosine (oral) | (5.6 Viral infection) |
| | Difelikefalin | (13.6 Pruritis) |
| | Digoxin (intravenous) | (2.1 Arrhythmias) |
| | Digoxin-specific antibody fragments | (2.1 Arrhythmias) |
| | Dimethyl fumarate (oral) | (13.3 Inflammatory skin conditions) |
| | Dimethyl fumarate (oral) | (8.1 Immune system) |
| | Dinoprostone pessaries (Propess) | (7.5 Obstetrics) |
| | Dinoprostone vaginal tablet & vaginal gel (Prostin E2) | (7.5 Obstetrics) |
| | Dinutuximab beta (parenteral) | (8.2 Malignant disease) |
| | Dipotassium hydrogen phosphate | (9.2 Fluid and electrolyte imbalances) |
| | Diroximel fumarate (oral) | (8.1 Immune system) |
| | Disodium pamidronate | (6.4 Disorders of bone metabolism) |
| | Dithranol in Lassar’s paste 0.1 to 2% | (13.3 Inflammatory skin conditions) |
| | Dobutamine | (2.7 Myocardial ischaemia) |
| | Docetaxel (parenteral) | (8.2 Malignant disease) |
| | Dolutegravir (oral) | (5.6 Viral infection) |
| | Dolutegravir / Lamivudine (oral) (Dovato) | (5.6 Viral infection) |
| | Dolutegravir / Rilpivirine (oral) (Juluca) | (5.6 Viral infection) |
| | Doravirine (oral) | (5.6 Viral infection) |
| | Doravirine / Lamivudine / Tenofovir disoproxil fumarate (oral) (Delstrigo) | (5.6 Viral infection) |
| | Dornase alfa | (3.3 Conditions affecting sputum viscosity) |
| | Dostarlimab | (8.2 Malignant disease) |
| | Doxapram | (3.6 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Doxepin hydrochloride 5% cream | (13.6 Pruritis) |
| | Doxorubicin (parenteral) | (8.2 Malignant disease) |
| | Doxorubicin, pegylated liposomal (parenteral) | (8.2 Malignant disease) |
| | Droperidol | (4.2 Mental health disorders) |
| | Droperidol | (4.4 Nausea and labyrinth disorders) |
| | Dupilumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Dupilumab | (3.1 Airways disease, obstructive) |
| | Durvalumab (parenteral) | (8.2 Malignant disease) |
| | Eculizumab | (9.1 Blood and blood–forming organs) |
| | Efavirenz (oral) | (5.6 Viral infection) |
| | Elafibranor | (1.7 Liver disorders and related conditions) |
| | Elbasvir / Grazoprevir (oral) (Zepatier) | (5.6 Viral infection) |
| | Eleview lifting solution | (17.1 Miscellaneous Preparations) |
| | Elexacaftor / Tezacaftor / Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Elranatamab | (8.2 Malignant disease) |
| | Eltrombopag | (9.1 Blood and blood–forming organs) |
| | Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide (oral) (Genvoya) | (5.6 Viral infection) |
| | Emicizumab | (2.3 Blood clots) |
| | Emtricitabine (oral) | (5.6 Viral infection) |
| | Emtricitabine / Tenofovir Alafenamide (oral) (Descovy) | (5.6 Viral infection) |
| | Emtricitabine / Tenofovir disoproxil | (5.6 Viral infection) |
| | Encorafenib (oral) | (8.2 Malignant disease) |
| | Enfuvirtide (parenteral) | (5.6 Viral infection) |
| | Enoximone | (2.5 Heart Failure) |
| | Entecavir (oral) | (5.6 Viral infection) |
| | Entrectinib | (8.2 Malignant disease) |
| | Enzalutamide (oral) | (8.2 Malignant disease) |
| | Epcoritamab | (8.2 Malignant disease) |
| | Ephedrine hydrochloride tablets | (2.4 Blood pressure conditions) |
| | Ephedrine | (2.4 Blood pressure conditions) |
| | Epirubicin (parenteral) | (8.2 Malignant disease) |
| | Epoprostenol (intravenous) | (2.4 Blood pressure conditions) |
| | Epoprostenol | (2.3 Blood clots) |
| | Eptifibatide (Integrellin) | (2.3 Blood clots) |
| | Eptinezumab | (4.5 Pain) |
| | Erenumab | (4.5 Pain) |
| | Ergocalciferol (parenteral) | (9.6 Vitamin deficiencies) |
| | Ergometrine | (7.5 Obstetrics) |
| | Eribulin (parenteral) | (8.2 Malignant disease) |
| | Erlotinib (oral) | (8.2 Malignant disease) |
| | Erythromycin (parenteral) | (5.2 Bacterial infection) |
| | Erythromycin 0.5% eye ointment (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Erythropoietin (Epoetin) beta | (9.1 Blood and blood–forming organs) |
| | Esmolol (intravenous) | (2.4 Blood pressure conditions) |
| | Etanercept (parenteral) | (13.3 Inflammatory skin conditions) |
| | Etanercept | (10.1 Arthritis) |
| | Etelcalcetide | (9.2 Fluid and electrolyte imbalances) |
| | Ethambutol hydrochloride (oral) | (5.2 Bacterial infection) |
| | Ethanolamine oleate | (2.9 Vascular disease) |
| | Etomidate | (15.1 General Anaesthesia) |
| | Etoposide (oral & parenteral) | (8.2 Malignant disease) |
| | Etoposide phosphate (parenteral) | (8.2 Malignant disease) |
| | Etranacogene dezaparvovec | (2.2 Bleeding disorders) |
| | Etrasimod | (1.1 Chronic bowel disorders) |
| | Etravirine (oral) | (5.6 Viral infection) |
| | Everolimus (oral) | (8.2 Malignant disease) |
| | Evinacumab | (2.6 Hyperlipidaemia) |
| | Evolocumab | (2.6 Hyperlipidaemia) |
| | Exagamglogene autotemcel | (9.1 Blood and blood–forming organs) |
| | Faecal Microbiota Transplant | (5.2 Bacterial infection) |
| | Faricimab | (11.8 Miscellaneous ophthalmic preparations) |
| | Fedratinib | (8.2 Malignant disease) |
| | Fenfluramine | (4.6 Seizures) |
| | Fentanyl | (15.1 General Anaesthesia) |
| | Ferric carboxymaltose (Ferinject) | (9.1 Blood and blood–forming organs) |
| | Ferric derisomaltose (previously known as Monofer) | (9.1 Blood and blood–forming organs) |
| | Fibryga (Human Fibrinogen) | (7.5 Obstetrics) |
| | Filgotinib | (1.1 Chronic bowel disorders) |
| | Filgotinib | (10.1 Arthritis) |
| | Fingolimod (oral) | (8.1 Immune system) |
| | Flammacerium cream | (13.2 Infections of the skin) |
| | Flecainide (intravenous) | (2.1 Arrhythmias) |
| | Fluconazole (parenteral) | (5.3 Fungal infection) |
| | Flucytosine (oral & parenteral) | (5.3 Fungal infection) |
| | Fludarabine (oral & parenteral) | (8.2 Malignant disease) |
| | Fluocinolone acetonide intravitreal injection 190micrograms (Iluvien) | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Fluorouracil (parenteral) | (8.2 Malignant disease) |
| | Follitropin beta | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Fondaparinux | (2.3 Blood clots) |
| | Fosaprepitant | (4.4 Nausea and labyrinth disorders) |
| | Foscarnet sodium (parenteral) | (5.6 Viral infection) |
| | Foslevodopa–foscarbidopa | (4.3 Movement disorders) |
| | Fostamatinib | (9.1 Blood and blood–forming organs) |
| | Fremanezumab | (4.5 Pain) |
| | Futibatinib | (8.2 Malignant disease) |
| | Gabapentin | (3.4 Cough and congestion) |
| | Galcanezumab | (4.5 Pain) |
| | Ganciclovir (parenteral) | (5.6 Viral infection) |
| | Gefitinib (oral) | (8.2 Malignant disease) |
| | Gemcitabine (parenteral) | (8.2 Malignant disease) |
| | Gemeprost pessary | (7.5 Obstetrics) |
| | Gemtuzumab ozogamicin (parenteral) | (8.2 Malignant disease) |
| | Gentamicin (intravesical) | (5.2 Bacterial infection) |
| | Gentamicin (nebulised) | (5.2 Bacterial infection) |
| | Gentamicin 0.1% cream | (13.2 Infections of the skin) |
| | Gentamicin 1.5% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Gilteritinib | (8.2 Malignant disease) |
| | Glatiramer acetate (parenteral) | (8.1 Immune system) |
| | Glecaprevir / Pibrentasvir (oral) | (5.6 Viral infection) |
| | Glofitamab | (8.2 Malignant disease) |
| | Glucarpidase | (8.2 Malignant disease) |
| | Glycerol phenylbutyrate (Ravicti) | (9.3 Metabolic disorders) |
| | Glycopyrronium | (15.1 General Anaesthesia) |
| | Golimumab | (1.1 Chronic bowel disorders) |
| | Golimumab | (10.1 Arthritis) |
| | Goserelin 3.6mg implant (Zoladex) | (6.6 Gonadotrophin responsive conditions) |
| | Granisetron | (4.4 Nausea and labyrinth disorders) |
| | Grazax | (3.2 Allergic conditions) |
| | Guselkumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Guselkumab | (10.1 Arthritis) |
| | Haem arginate infusion | (9.3 Metabolic disorders) |
| | Haloperidol (injection- non depot) | (4.2 Mental health disorders) |
| | Heparin Calcium | (2.3 Blood clots) |
| | Heparin Sodium | (2.3 Blood clots) |
| | Hepatitis B immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Hepatitis B vaccine (HBvaxPRO 40microgram, Energix B) | (14.4 Vaccination) |
| | Hexamidine 0.1% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Hexaminolevulinate (Hexvix) | (17.1 Miscellaneous Preparations) |
| | Human normal immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Humulin R U500 | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Hydralazine (intravenous) | (2.4 Blood pressure conditions) |
| | Hydrocortisone sodium phosphate 3.35mg/mL eye drops (Softacort) | (11.4 Corticosteroids and other anti–inflammatory preparations) |
| | Hydroquinone 5% / Hydrocortisone 1% / Tretinoin 0.1% cream (Pigmanorm) | (13.3 Inflammatory skin conditions) |
| | HyloDual preservative free eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Ibandronic acid 2mg injection | (6.4 Disorders of bone metabolism) |
| | Ibandronic acid 3mg injection | (6.4 Disorders of bone metabolism) |
| | Ibrutinib (oral) | (8.2 Malignant disease) |
| | Icatibant (Firazyr) | (3.2 Allergic conditions) |
| | Idarubicin (oral) | (8.2 Malignant disease) |
| | Idarucizumab | (2.3 Blood clots) |
| | Idelalisib (oral) | (8.2 Malignant disease) |
| | Idursulfase | (9.3 Metabolic disorders) |
| | Ifosfamide (parenteral) | (8.2 Malignant disease) |
| | Iloprost | (2.4 Blood pressure conditions) |
| | Imatinib (oral) | (8.2 Malignant disease) |
| | Imiglucerase | (9.3 Metabolic disorders) |
| | Imlifidase | (8.1 Immune system) |
| | Independence Wound Protection/Collection Pouch Covers: VAP 1 (small), VAP 2 (regular), VAP 3 (large) | (17.1 Miscellaneous Preparations) |
| | Indinavir (oral) | (5.6 Viral infection) |
| | Infliximab (intravenous & subcutaneous) | (1.1 Chronic bowel disorders) |
| | Infliximab (intravenous & subcutaneous) | (13.3 Inflammatory skin conditions) |
| | Infliximab (intravenous & subcutaneous) | (4.3 Movement disorders) |
| | Infliximab | (10.1 Arthritis) |
| | Infliximab | (10.5 Soft tissue and joint disorders) |
| | Inotuzumab ozogamicin (parenteral) | (8.2 Malignant disease) |
| | Insulin eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Interferon alfa (Roferon-A) (parenteral) | (5.6 Viral infection) |
| | Interferon alfa (Roferon-A) (parenteral) | (8.2 Malignant disease) |
| | Interferon alfa-2a 1 million units in 1mL eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Interferon alfa-2b 1 million units in 1mL eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Interferon beta (parenteral) | (8.1 Immune system) |
| | Interferon beta (parenteral) | (8.2 Malignant disease) |
| | Ipilimumab (parenteral) | (8.2 Malignant disease) |
| | Irinotecan hydrochloride (parenteral) | (8.2 Malignant disease) |
| | Iron dextran (CosmoFer) | (9.1 Blood and blood–forming organs) |
| | Iron sucrose (Venofer) | (9.1 Blood and blood–forming organs) |
| | Isatuximab (parenteral) | (8.2 Malignant disease) |
| | Isavuconazole (oral & parenteral) | (5.3 Fungal infection) |
| | Isoflurane | (15.1 General Anaesthesia) |
| | Isoniazid (oral) | (5.2 Bacterial infection) |
| | Isoprenaline | (2.7 Myocardial ischaemia) |
| | Isosorbide dinitrate Infusion | (2.7 Myocardial ischaemia) |
| | Isotretinoin capsules | (13.7 Rosacea and acne) |
| | Itulazax (Standardised allergen extract of pollen from white birch [Betula verrucosa]) | (3.2 Allergic conditions) |
| | Ivacaftor / Tezacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Ivermectin (oral) (unlicensed) | (5.4 Helminth infection) |
| | Ivermectin (oral) | (13.2 Infections of the skin) |
| | Ivosidenib | (8.2 Malignant disease) |
| | Ixazomib with Lenalidomide and Dexamethasone | (8.2 Malignant disease) |
| | Ixekizumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Ixekizumab | (10.1 Arthritis) |
| | Ketamine | (15.1 General Anaesthesia) |
| | Ketamine | (16.1 Pain due to cancer in adults- Palliative Care) |
| | Ketamine | (4.2 Mental health disorders) |
| | Ketamine | (4.5 Pain) |
| | Ketorolac injection | (15.1 General Anaesthesia) |
| | Ketorolac | (10.4 Pain and inflammation in musculoskeletal disorders) |
| | Labetalol (intravenous) | (2.4 Blood pressure conditions) |
| | Lamivudine (oral) | (5.6 Viral infection) |
| | Lanadelumab | (3.2 Allergic conditions) |
| | Lanreotide (parenteral) | (8.2 Malignant disease) |
| | Larotrectinib | (8.2 Malignant disease) |
| | LAT (Lidocaine, Adrenaline and Tetracaine) gel | (15.2 Local anaesthesia) |
| | Lebrikizumab | (13.3 Inflammatory skin conditions) |
| | Ledipasvir / Sofosbuvir | (5.6 Viral infection) |
| | Lenalidomide (oral) | (8.2 Malignant disease) |
| | Lenvatinib with Everolimus (oral) | (8.2 Malignant disease) |
| | Lenvatinib | (8.2 Malignant disease) |
| | Letermovir (oral) | (5.6 Viral infection) |
| | Levamisole (oral) (unlicensed) | (5.4 Helminth infection) |
| | Levetiracetam (parenteral) | (4.6 Seizures) |
| | Levobupivacaine 2.5mg/mL, 5mg/mL & 7.5mg/mL injection | (15.2 Local anaesthesia) |
| | Levofloxacin (nebulised) | (5.2 Bacterial infection) |
| | Levofloxacin (parenteral) | (5.2 Bacterial infection) |
| | Levosimendan | (2.5 Heart Failure) |
| | Lidocaine 4% / Fluorescein 0.25% single-use eye drops | (11.7 Local anaesthetics) |
| | Lidocaine patch | (4.5 Pain) |
| | Lidocaine | (2.1 Arrhythmias) |
| | Linezolid (oral & parenteral) | (5.2 Bacterial infection) |
| | Liothyronine | (6.9 Thyroid disorders) |
| | Liposomal amphotericin (parenteral) | (5.3 Fungal infection) |
| | Liraglutide (Saxenda) | (1.8 Obesity) |
| | Lomitapide | (2.6 Hyperlipidaemia) |
| | Lomustine (oral) | (8.2 Malignant disease) |
| | Loncastuximab tesirine | (8.2 Malignant disease) |
| | Lopinavir / Ritonavir (oral) (Kaletra) | (5.6 Viral infection) |
| | Lorlatinib | (8.2 Malignant disease) |
| | Lumacaftor / Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Lumasiran | (9.3 Metabolic disorders) |
| | Lusutrombopag | (9.1 Blood and blood–forming organs) |
| | Lutetium (177Lu) oxodotreotide | (17.1 Miscellaneous Preparations) |
| | Lutetium (177Lu) vipivotide tetraxetan | (17.1 Miscellaneous Preparations) |
| | Macimorelin | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Magnesium sulfate (unlicensed indications) | (7.5 Obstetrics) |
| | Magnesium sulphate 50% (parenteral) | (9.2 Fluid and electrolyte imbalances) |
| | Magnesium sulphate | (2.1 Arrhythmias) |
| | MagTab | (9.2 Fluid and electrolyte imbalances) |
| | Mannitol dry powder for inhalation | (3.3 Conditions affecting sputum viscosity) |
| | Mannitol Infusion 20% | (2.8 Oedema) |
| | Maraviroc (oral) | (5.6 Viral infection) |
| | Maribavir | (5.6 Viral infection) |
| | Mavacamten | (2.5 Heart Failure) |
| | Mefloquine (oral) | (5.5 Protozoal infection) |
| | Melatonin modified-release | (4.7 Sleep disorders) |
| | Melatonin | (4.7 Sleep disorders) |
| | Melphalan (oral & parenteral) | (8.2 Malignant disease) |
| | Meningococcal Group B vaccine (Bexsero) | (14.4 Vaccination) |
| | Mepolizumab | (3.1 Airways disease, obstructive) |
| | Mercaptamine | (11.8 Miscellaneous ophthalmic preparations) |
| | Mercaptamine | (9.3 Metabolic disorders) |
| | Mercaptopurine (oral) | (8.2 Malignant disease) |
| | Meropenem (parenteral) | (5.2 Bacterial infection) |
| | Metaraminol | (2.4 Blood pressure conditions) |
| | Methacholine (Provocholine) powder for nebuliser solution | (3.6 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Methohexitone | (15.1 General Anaesthesia) |
| | Methotrexate (parenteral) | (8.2 Malignant disease) |
| | Methoxsalen (Uvadex) | (17.1 Miscellaneous Preparations) |
| | Methoxy polyethylene glycol-epoetin beta (Mircera) | (9.1 Blood and blood–forming organs) |
| | Methoxyflurane (inhaled) (Penthrox) | (15.1 General Anaesthesia) |
| | Methoxyflurane (inhaled) (Penthrox) | (15.1 General Anaesthesia) |
| | Methoxyflurane (inhaled) (Penthrox) | (15.1 General Anaesthesia) |
| | Methyl aminolevulinate (Metvix) | (13.5 Photodamage) |
| | Methylphenidate | (4.7 Sleep disorders) |
| | Methysergide | (4.5 Pain) |
| | Metoprolol (intravenous) | (2.4 Blood pressure conditions) |
| | Metronidazole (parenteral) | (5.2 Bacterial infection) |
| | Mexiletine (NaMuscla) | (4.3 Movement disorders) |
| | Mexiletine | (2.1 Arrhythmias) |
| | Micafungin (parenteral) | (5.3 Fungal infection) |
| | Midazolam (parenteral) | (4.6 Seizures) |
| | Midazolam 40mg/mL / Lignocaine 20mg/mL nasal solution | (15.1 General Anaesthesia) |
| | Midodrine | (2.4 Blood pressure conditions) |
| | Midostaurin (oral) | (8.2 Malignant disease) |
| | Mifamurtide (parenteral) | (8.2 Malignant disease) |
| | Mifepristone (oral) | (7.3 Contraception) |
| | Mifepristone | (7.5 Obstetrics) |
| | Milrinone | (2.5 Heart Failure) |
| | Mirikizumab | (1.1 Chronic bowel disorders) |
| | Misoprostol (oral) | (7.5 Obstetrics) |
| | Misoprostol | (7.3 Contraception) |
| | Mitomycin (parenteral & bladder instillation) | (8.2 Malignant disease) |
| | Mitomycin 0.02% and 0.04% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Mitotane (oral) | (8.2 Malignant disease) |
| | Mitoxantrone (parenteral) | (8.2 Malignant disease) |
| | Mivacurium | (15.1 General Anaesthesia) |
| | Mobocertinib (oral) | (8.2 Malignant disease) |
| | Mogamulizumab | (8.2 Malignant disease) |
| | Molnupiravir (Lagevrio) | (5.7 Treatment of COVID-19) |
| | Momelotinib | (8.2 Malignant disease) |
| | Morphine sulfate modified release tablets | (3.4 Cough and congestion) |
| | Morphine | (15.1 General Anaesthesia) |
| | Moxifloxacin 0.5% eye drops (Moxivig) | (11.3 Anti–infective eye preparations) |
| | Mycophenolate mofetil (oral & parenteral) | (8.1 Immune system) |
| | Mycophenolic acid (as mycophenolate sodium) (oral) | (8.1 Immune system) |
| | N-acetylcisteine (NAC) mixed with simeticone | (17.1 Miscellaneous Preparations) |
| | Nalmefene | (4.8 Substance dependence) |
| | Natalizumab (parenteral) | (8.1 Immune system) |
| | Nelarabine (parenteral) | (8.2 Malignant disease) |
| | Nelfinavir (oral) | (5.6 Viral infection) |
| | Neostigmine / Glycopyrronium | (15.1 General Anaesthesia) |
| | Neostigmine | (15.1 General Anaesthesia) |
| | Neratinib (oral) | (8.2 Malignant disease) |
| | Netupitant 300mg / Palonosetron 0.5mg (Akynzeo) | (4.4 Nausea and labyrinth disorders) |
| | Nevirapine (oral) | (5.6 Viral infection) |
| | Nicardipine (intravenous) | (2.4 Blood pressure conditions) |
| | Nifedipine (unlicensed) | (7.5 Obstetrics) |
| | Nilotinib (oral) | (8.2 Malignant disease) |
| | Nimodipine | (2.4 Blood pressure conditions) |
| | Nimodipine | (2.2 Bleeding disorders) |
| | Nintedanib (oral) | (8.2 Malignant disease) |
| | Nintedanib | (3.5 Interstitial Lung Disease) |
| | Niraparib (oral) | (8.2 Malignant disease) |
| | Nirmatrelvir and Ritonavir (Paxlovid) | (5.7 Treatment of COVID-19) |
| | Nitrous oxide | (15.1 General Anaesthesia) |
| | Nivolumab (parenteral) | (8.2 Malignant disease) |
| | Normal human immunoglobulins | (14.1 Immunoglobulin therapy) |
| | Nusinersen | (10.3 Neuromuscular disorders) |
| | Nutritain | (9.6 Vitamin deficiencies) |
| | Nutryelt | (9.4 Trace element deficiencies) |
| | Obeticholic Acid | (1.7 Liver disorders and related conditions) |
| | Obinutuzumab (parenteral) | (8.2 Malignant disease) |
| | Ocrelizumab (parenteral) | (8.1 Immune system) |
| | Octreotide (parenteral) | (8.2 Malignant disease) |
| | Octreotide | (16.2 Gastrointestinal symptoms- Palliative Care) |
| | Ofatumumab (parenteral) | (8.1 Immune system) |
| | Ofloxacin (parenteral) | (5.2 Bacterial infection) |
| | Olaparib | (8.2 Malignant disease) |
| | Omalizumab | (13.3 Inflammatory skin conditions) |
| | Omalizumab | (3.1 Airways disease, obstructive) |
| | Ombitasvir / Paritaprevir / Ritonavir (oral) (Viekirax) | (5.6 Viral infection) |
| | Ombitasvir / Paritaprevir / Ritonavir with Dasabuvir (oral) (Exviera) | (5.6 Viral infection) |
| | Onasemnogene abeparvovec | (10.3 Neuromuscular disorders) |
| | OralVac | (3.2 Allergic conditions) |
| | Oritavancin (parenteral) | (5.2 Bacterial infection) |
| | Osimertinib (oral) | (8.2 Malignant disease) |
| | Oxaliplatin (parenteral) | (8.2 Malignant disease) |
| | Oxybuprocaine 0.4% single-use eye drops | (11.7 Local anaesthetics) |
| | Oxycodone (PCA) | (4.5 Pain) |
| | Oxytocin (parenteral) | (7.5 Obstetrics) |
| | Oxytocin / Ergometrine (Syntometrine) | (7.5 Obstetrics) |
| | Oxytocin | (7.5 Obstetrics) |
| | Ozanimod | (1.1 Chronic bowel disorders) |
| | Paclitaxel (parenteral) | (8.2 Malignant disease) |
| | Palbociclib (oral) | (8.2 Malignant disease) |
| | Paliperidone palmitate injection (Xeplion) | (4.2 Mental health disorders) |
| | Palivizumab | (5.6 Viral infection) |
| | Palonosetron | (4.4 Nausea and labyrinth disorders) |
| | Pancuronium | (15.1 General Anaesthesia) |
| | Panitumumab (parenteral) | (8.2 Malignant disease) |
| | Panobinostat (oral) | (8.2 Malignant disease) |
| | Paraldehyde | (4.6 Seizures) |
| | Parecoxib | (15.1 General Anaesthesia) |
| | Pasireotide (subcutaneous) | (8.2 Malignant disease) |
| | Pasireotide | (6.2 Corticosteroid responsive conditions) |
| | Patiromer | (9.2 Fluid and electrolyte imbalances) |
| | Pazopanib (oral) | (8.2 Malignant disease) |
| | Pegaspargase | (8.2 Malignant disease) |
| | Pegcetacoplan | (9.1 Blood and blood–forming organs) |
| | Peginterferon alfa (parenteral) | (5.6 Viral infection) |
| | Peginterferon alfa (parenteral) | (8.2 Malignant disease) |
| | Peginterferon beta-1a | (8.2 Malignant disease) |
| | Pegunigalsidase alfa | (9.3 Metabolic disorders) |
| | Pegvisomant | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Pembrolizumab (parenteral) | (8.2 Malignant disease) |
| | Pemetrexed (parenteral) | (8.2 Malignant disease) |
| | Pemigatinib (oral) | (8.2 Malignant disease) |
| | Pentamidine (nebulised) | (5.3 Fungal infection) |
| | Pentamidine (parenteral) | (5.3 Fungal infection) |
| | Pentosan polysulfate sodium | (7.1 Bladder and urinary disorders) |
| | Pentostatin (parenteral) | (8.2 Malignant disease) |
| | Peppermint oil enema | (1.2 Constipation and bowel cleansing) |
| | Perflutren (Luminity) | (17.1 Miscellaneous Preparations) |
| | Pertuzumab (parenteral) | (8.2 Malignant disease) |
| | Phenobarbital (parenteral) | (4.6 Seizures) |
| | Phenoxybenzamine | (2.4 Blood pressure conditions) |
| | Phentolamine | (2.4 Blood pressure conditions) |
| | Phenylephrine 2.5% eye drops (unlicensed) | (11.5 Mydriatics and cycloplegics) |
| | Phenylephrine | (2.4 Blood pressure conditions) |
| | PHMB (Polyhexamethylene biguanide hydrochloride) 0.02% and 0.06% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Piperacillin / Tazobactam (parenteral) | (5.2 Bacterial infection) |
| | Pirfenidone | (3.5 Interstitial Lung Disease) |
| | Pixantrone (parenteral) | (8.2 Malignant disease) |
| | Plasma-Lyte 148 | (9.5 Nutrition) |
| | Polatuzumab vedotin (parenteral) | (8.2 Malignant disease) |
| | Pollinex | (3.2 Allergic conditions) |
| | Pomalidomide (oral) | (8.2 Malignant disease) |
| | Ponatinib (oral) | (8.2 Malignant disease) |
| | Ponesimod (oral) | (8.1 Immune system) |
| | Posaconazole (oral) | (5.3 Fungal infection) |
| | Potassium acid phosphate sterile solution for injection {13.6%} | (9.2 Fluid and electrolyte imbalances) |
| | Potassium ascorbate 10% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Potassium Chloride 600mg (8mmol) modified release tablets | (9.2 Fluid and electrolyte imbalances) |
| | Potassium chloride prefilled syringe (50mmol/50mL {7.5%}) | (9.2 Fluid and electrolyte imbalances) |
| | Prasterone (DHEA) gel | (7.6 Vaginal and vulval conditions) |
| | Praziquantel (oral) (unlicensed) | (5.4 Helminth infection) |
| | Praziquantel (oral) (unlicensed) | (5.4 Helminth infection) |
| | Primaquine (oral) (unlicensed) | (5.3 Fungal infection) |
| | Primaquine (oral) (unlicensed) | (5.5 Protozoal infection) |
| | Pristinamycin (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Probenecid | (5.2 Bacterial infection) |
| | Procaine benzylpenicillin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Procarbazine (oral) | (8.2 Malignant disease) |
| | Progesterone pessaries (Cyclogest) | (7.5 Obstetrics) |
| | Proguanil hydrochloride (oral) | (5.5 Protozoal infection) |
| | Proguanil hydrochloride / Atovaquone (oral) (Malarone) | (5.5 Protozoal infection) |
| | Prontoderm Foam | (13.9 Skin cleansers, antiseptics and desloughing agents) |
| | Propafenone (intravenous) | (2.1 Arrhythmias) |
| | Propofol 1% (10mg/mL) | (15.1 General Anaesthesia) |
| | Propofol 2% (20mg/mL) | (15.1 General Anaesthesia) |
| | Propofol | (4.6 Seizures) |
| | Protamine | (2.3 Blood clots) |
| | Prothionamide (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Proxymetacaine 0.5% single-use eye drops | (11.7 Local anaesthetics) |
| | Pyrazinamide (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Pyrimethamine (oral) | (5.5 Protozoal infection) |
| | Pyrimethamine / Sulfadoxine (oral) (unlicensed) (Fansidar) | (5.5 Protozoal infection) |
| | Quinagolide | (6.5 Dopamine responsive conditions) |
| | Quixil | (2.2 Bleeding disorders) |
| | Quizartinib | (8.2 Malignant disease) |
| | Rabies immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Raltegravir (oral) | (5.6 Viral infection) |
| | Ranibizumab | (11.8 Miscellaneous ophthalmic preparations) |
| | Rasburicase (parenteral) | (8.2 Malignant disease) |
| | Ravulizumab | (8.2 Malignant disease) |
| | Ravulizumab | (9.1 Blood and blood–forming organs) |
| | Regadenoson (Rapiscan) | (17.1 Miscellaneous Preparations) |
| | Regorafenib (oral) | (8.2 Malignant disease) |
| | Remdesivir | (5.7 Treatment of COVID-19) |
| | Remifentanil | (15.1 General Anaesthesia) |
| | Reslizumab | (3.1 Airways disease, obstructive) |
| | Rezafungin (parenteral) | (5.3 Fungal infection) |
| | Ribavirin (oral) | (5.6 Viral infection) |
| | Ribociclib (oral) | (8.2 Malignant disease) |
| | Rifabutin (oral) | (5.2 Bacterial infection) |
| | Rifampicin (oral) | (5.2 Bacterial infection) |
| | Rifampicin (parenteral) | (5.2 Bacterial infection) |
| | Rifampicin / Isoniazid (oral) (Rifinah) | (5.2 Bacterial infection) |
| | Rifampicin / Isoniazid / Pyrazinamide (oral) (Rifater) | (5.2 Bacterial infection) |
| | Rifampicin / Isoniazid / Pyrazinamide / Ethambutol (oral) (Voractiv) | (5.2 Bacterial infection) |
| | Rifaximin (oral) | (5.2 Bacterial infection) |
| | Rilpivirine (oral) | (5.6 Viral infection) |
| | Rilpivirine / Emtricitabine / Tenofovir (oral) (Eviplera) | (5.6 Viral infection) |
| | Rilpivirine / Emtricitabine / Tenofovir Alafenamide (oral) (Odefsey) | (5.6 Viral infection) |
| | Riociguat | (2.4 Blood pressure conditions) |
| | Risankizumab | (1.1 Chronic bowel disorders) |
| | Risankizumab | (10.1 Arthritis) |
| | Risankizumab | (13.3 Inflammatory skin conditions) |
| | Risdiplam | (10.3 Neuromuscular disorders) |
| | Risperidone injection (Consta) | (4.2 Mental health disorders) |
| | Ritlecitinib | (13.8 Scalp and hair conditions) |
| | Ritonavir (oral) | (5.6 Viral infection) |
| | Rituximab (parenteral) | (8.2 Malignant disease) |
| | Rituximab biosimilar (parenteral) | (8.2 Malignant disease) |
| | Rituximab | (10.1 Arthritis) |
| | Rivaroxaban | (2.3 Blood clots) |
| | Rocuronium | (15.1 General Anaesthesia) |
| | Romiplostim | (9.1 Blood and blood–forming organs) |
| | Romosozumab | (6.4 Disorders of bone metabolism) |
| | Ropivacaine | (15.2 Local anaesthesia) |
| | Roxadustat | (9.1 Blood and blood–forming organs) |
| | Rucaparib | (8.2 Malignant disease) |
| | Ruxolitinib (oral) | (8.2 Malignant disease) |
| | Sacituzumab govitecan | (8.2 Malignant disease) |
| | Sapropterin dihydrochloride | (9.5 Nutrition) |
| | Saquinavir (oral) | (5.6 Viral infection) |
| | Sarilumab | (10.1 Arthritis) |
| | Secukinumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Secukinumab | (10.1 Arthritis) |
| | Selective Internal Radiation Therapies | (8.2 Malignant disease) |
| | Selenase oral solution | (9.4 Trace element deficiencies) |
| | Selinexor | (8.2 Malignant disease) |
| | Selpercatinib | (8.2 Malignant disease) |
| | Semaglutide (Wegovy) | (1.8 Obesity) |
| | Sevelamer carbonate sachets | (9.2 Fluid and electrolyte imbalances) |
| | Sevoflurane | (15.1 General Anaesthesia) |
| | Sildenafil (oral & parenteral) | (2.4 Blood pressure conditions) |
| | Siltuximab | (8.1 Immune system) |
| | Siponimod (oral) | (8.1 Immune system) |
| | Sirolimus (oral) | (8.1 Immune system) |
| | Sodium aurothiomalate | (10.1 Arthritis) |
| | Sodium chloride 5% | (9.2 Fluid and electrolyte imbalances) |
| | Sodium clodronate (Clasteon® or Loron) | (6.4 Disorders of bone metabolism) |
| | Sodium nitroprusside | (2.4 Blood pressure conditions) |
| | Sodium oxybate | (4.7 Sleep disorders) |
| | Sodium tetradecyl sulphate | (2.9 Vascular disease) |
| | Sodium thiopentone | (4.6 Seizures) |
| | Sodium valproate (parenteral) | (4.6 Seizures) |
| | Sodium valproate injection | (4.6 Seizures) |
| | Sodium zirconium cyclosilicate | (9.2 Fluid and electrolyte imbalances) |
| | Sofosbuvir (oral) | (5.6 Viral infection) |
| | Sofosbuvir / Velpatasvir / Voxilaprevir | (5.6 Viral infection) |
| | Sofosbuvir / Velpatasvir | (5.6 Viral infection) |
| | Solriamfetol | (4.7 Sleep disorders) |
| | Somatropin (synthetic Human Growth Hormone) | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Sorafenib (oral) | (8.2 Malignant disease) |
| | Sotalol (intravenous) | (2.1 Arrhythmias) |
| | Sotorasib (oral) | (8.2 Malignant disease) |
| | Sotrovimab (Xevudy) | (5.7 Treatment of COVID-19) |
| | Stavudine (oral) | (5.6 Viral infection) |
| | Sterile potassium chloride concentrate (20mmol/10mL {15%}) | (9.2 Fluid and electrolyte imbalances) |
| | Streptokinase | (2.7 Myocardial ischaemia) |
| | Streptomycin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Succinylated gelatin 40g (4%) (Gelofusine, Isoplex) | (9.2 Fluid and electrolyte imbalances) |
| | Sucralfate 3g/20mL enema | (1.4 Disorders of gastric acid and ulceration) |
| | Sucralfate liquid (oral) | (12.3 Oropharynx) |
| | Sugammadex | (15.1 General Anaesthesia) |
| | Sulfur hexafluoride lipid microspheres (SonoVue) | (17.1 Miscellaneous Preparations) |
| | Sunitinib (oral) | (8.2 Malignant disease) |
| | Suxamethonium | (15.1 General Anaesthesia) |
| | Tacrolimus (oral & parenteral) | (8.1 Immune system) |
| | Tacrolimus 0.03%, 0.1% ointment (unlicensed) | (11.8 Miscellaneous ophthalmic preparations) |
| | Tadalafil (oral) | (2.4 Blood pressure conditions) |
| | Tafamidis | (2.5 Heart Failure) |
| | Talazoparib | (8.2 Malignant disease) |
| | Talimogene (parenteral) | (8.2 Malignant disease) |
| | Talimogene laherparepvec (parenteral) | (8.2 Malignant disease) |
| | Tapentadol immediate-release | (4.5 Pain) |
| | Teclistamab | (8.2 Malignant disease) |
| | Tecovirimat | (5.6 Viral infection) |
| | Teduglutide | (1.1 Chronic bowel disorders) |
| | Tegafur / Uracil (oral) | (8.2 Malignant disease) |
| | Teicoplanin (parenteral) | (5.2 Bacterial infection) |
| | Telbivudine (oral) | (5.6 Viral infection) |
| | Temocillin (parenteral) | (5.2 Bacterial infection) |
| | Temozolomide (oral) | (8.2 Malignant disease) |
| | Temsirolimus (parenteral) | (8.2 Malignant disease) |
| | Tenecteplase | (2.3 Blood clots) |
| | Tenecteplase | (2.7 Myocardial ischaemia) |
| | Tenofovir (oral) | (5.6 Viral infection) |
| | Tenofovir / Efavirenz / Emtricitabine (oral) (Atripla) | (5.6 Viral infection) |
| | Tenofovir / Efavirenz / Emtricitabine / Cobicistat (oral) (Stribild) | (5.6 Viral infection) |
| | Tenofovir disoproxil (oral) | (5.6 Viral infection) |
| | Tepotinib | (8.2 Malignant disease) |
| | Terbutaline | (7.5 Obstetrics) |
| | Teriflunomide (oral) | (8.1 Immune system) |
| | Teriparatide | (6.4 Disorders of bone metabolism) |
| | Terizidone (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Terlipressin | (1.7 Liver disorders and related conditions) |
| | Testosterone implant | (6.8 Sex hormone responsive conditions) |
| | Tetanus immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Tetracosactide 250micrograms & 1mg depot | (6.7 Hypothalamic and anterior pituitary hormone related disorders) |
| | Tezepelumab | (3.1 Airways disease, obstructive) |
| | Thalidomide (oral) (Celgene) | (8.2 Malignant disease) |
| | Thalidomide | (3.4 Cough and congestion) |
| | Thealoz Duo preservative free eye drops | (11.8 Miscellaneous ophthalmic preparations) |
| | Thiamine (parenteral) as Pabrinex | (4.6 Seizures) |
| | Thiopental sodium | (15.1 General Anaesthesia) |
| | Thiotepa (parenteral) | (8.2 Malignant disease) |
| | Tigecycline (parenteral) | (5.2 Bacterial infection) |
| | Tigecycline (parenteral) | (5.2 Bacterial infection) |
| | Tildrakizumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Tioguanine (Thioguanine) (oral) | (8.2 Malignant disease) |
| | Tiopronin | (9.3 Metabolic disorders) |
| | Tirofiban | (2.3 Blood clots) |
| | Tirofiban | (2.7 Myocardial ischaemia) |
| | Tisagenlecleucel | (8.2 Malignant disease) |
| | Tisseel | (2.2 Bleeding disorders) |
| | Tivozanib (oral) | (8.2 Malignant disease) |
| | Tobramycin (inhaled) | (3.1 Airways disease, obstructive) |
| | Tobramycin (inhaled) | (5.2 Bacterial infection) |
| | Tobramycin (nebulised) | (3.1 Airways disease, obstructive) |
| | Tobramycin (nebulised) | (5.2 Bacterial infection) |
| | Tobramycin (parenteral) | (3.1 Airways disease, obstructive) |
| | Tobramycin (parenteral) | (5.2 Bacterial infection) |
| | Tocilizumab | (10.1 Arthritis) |
| | Tocilizumab | (5.7 Treatment of COVID-19) |
| | Tofacitinib | (1.1 Chronic bowel disorders) |
| | Tofacitinib | (10.1 Arthritis) |
| | Tolcapone | (4.3 Movement disorders) |
| | Tolvaptan | (6.1 Antidiuretic hormone disorders) |
| | Topotecan (oral) | (8.2 Malignant disease) |
| | Trabectedin (parenteral) | (8.2 Malignant disease) |
| | Tralokinumab | (13.3 Inflammatory skin conditions) |
| | Trametinib (oral) | (8.2 Malignant disease) |
| | Trastuzumab (parenteral) | (8.2 Malignant disease) |
| | Treosulfan (parenteral) | (8.2 Malignant disease) |
| | Tretinoin (oral) | (8.2 Malignant disease) |
| | Triamcinolone acetonide 0.1% / Gramicidin 0.025% / Neomycin sulphate 0.25% / Nystatin 100,000 units/g ointment (Otocomb Otic Ear) | (12.1 Ear) |
| | Trientine | (9.3 Metabolic disorders) |
| | Trifluridine-tipiracil (oral) | (8.2 Malignant disease) |
| | Triptorelin 3mg injection (Decapeptyl SR) | (6.6 Gonadotrophin responsive conditions) |
| | Tucatinib (oral) | (8.2 Malignant disease) |
| | Ubidecarenone (Co-enzyme Q10) | (9.3 Metabolic disorders) |
| | Ublituximab | (8.1 Immune system) |
| | Udderly Smooth cream | (13.1 Dry and scaling skin disorders) |
| | Ulipristal acetate (Esmya) | (7.3 Contraception) |
| | Upadacitinib | (1.1 Chronic bowel disorders) |
| | Upadacitinib | (10.1 Arthritis) |
| | Upadacitinib | (13.3 Inflammatory skin conditions) |
| | Urocit K | (7.1 Bladder and urinary disorders) |
| | Urokinase | (2.3 Blood clots) |
| | Uromune Sublingual Spray Vaccine | (5.2 Bacterial infection) |
| | Ustekinumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Ustekinumab | (1.1 Chronic bowel disorders) |
| | Ustekinumab | (10.1 Arthritis) |
| | Vaginal micronised progesterone (Cyclogest pessaries) | (7.5 Obstetrics) |
| | Valganciclovir (oral) | (5.6 Viral infection) |
| | Valganciclovir solution (oral) | (5.6 Viral infection) |
| | Vancomycin (parenteral) | (5.2 Bacterial infection) |
| | Vancomycin 1.4% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Vancomycin 5% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Vancomycin 50mg/mL (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Vandetanib (oral) | (8.2 Malignant disease) |
| | Varicella-Zoster immunoglobulin | (14.1 Immunoglobulin therapy) |
| | Varicella-Zoster vaccine (Varilrix) | (14.4 Vaccination) |
| | Vecuronium | (15.1 General Anaesthesia) |
| | Vedolizumab (intravenous & subcutaneous) | (1.1 Chronic bowel disorders) |
| | Vemurafenib (oral) | (8.2 Malignant disease) |
| | Venetoclax (oral) | (8.2 Malignant disease) |
| | Verapamil (immediate release tablets) | (4.5 Pain) |
| | Verapamil (intravenous) | (2.1 Arrhythmias) |
| | Verapamil | (2.2 Bleeding disorders) |
| | Veraseal | (17.1 Miscellaneous Preparations) |
| | Vericiguat | (2.5 Heart Failure) |
| | Verteporfin | (11.8 Miscellaneous ophthalmic preparations) |
| | Vigabatrin | (4.6 Seizures) |
| | Vinblastine (parenteral) | (8.2 Malignant disease) |
| | Vincristine (parenteral) | (8.2 Malignant disease) |
| | Vinorelbine (parenteral) | (8.2 Malignant disease) |
| | Vismodegib (oral) | (8.2 Malignant disease) |
| | Vitamins B & C high potency (intravenous) (Pabrinex) | (9.6 Vitamin deficiencies) |
| | Vitlipid N adult | (9.6 Vitamin deficiencies) |
| | Voclosporin | (10.1 Arthritis) |
| | Volanesorsen | (2.6 Hyperlipidaemia) |
| | Voriconazole (oral & parenteral) | (5.3 Fungal infection) |
| | Voriconazole 1% eye drops (unlicensed) | (11.3 Anti–infective eye preparations) |
| | Vutrisiran | (4.5 Pain) |
| | Zanamivir (intravenous) | (5.6 Viral infection) |
| | Zanubrutinib (oral) | (8.2 Malignant disease) |
| | Zidovudine (oral & parenteral) | (5.6 Viral infection) |
| | Zoledronic acid | (6.4 Disorders of bone metabolism) |